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Abstract 
Integrin-linked kinase (ILK) is a ubiquitous scaffold protein that mediates cellular responses 
to integrin stimulation by extracellular matrix proteins. Mice with inactivation of the Ilk gene 
in squamous epithelia display defects in skin regeneration after injury, failure to thrive, and 
perinatal death. ILK-deficient epidermis exhibits reduced adhesion to the basement 
membrane and impaired hair follicle morphogenesis. In culture, ILK-deficient keratinocytes 
fail to attach and spread efficiently, and demonstrate decreased survival. We now show that 
ILK-deficient keratinocytes exhibit a lower proliferative capacity and increased apoptosis in 
the absence or presence of growth factors. This reduced viability appears to be independent 
of the Akt pathway, as ILK-deficient cells exhibit normal levels of active, phosphorylated 
Akt. They do, however, display higher levels of cleaved caspase-3 and PARP, both 
associated with caspase-dependent programmed cell death. We have also observed an 
increase in γH2A.X, a marker of DNA double-strand breaks, which is also associated with 
increased levels of reactive oxygen species (ROS) in these cells. Thus, increased 
susceptibility to DNA damage due an increase in ROS may lead to decreased cell survival. 
Our findings underline a distinct, novel role for ILK in promoting keratinocyte survival and a 
normal redox state.  
Keywords
Integrin-linked kinase, epidermis, keratinocytes, caspases, DNA damage, apoptosis, 
intrinsic pathway, reactive oxygen species, cell survival, proliferation 
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Chapter 1 – Introduction 
1.1 Architecture of the skin 
The largest organ in the body is the skin and it serves a critical function as a protective 
barrier from external harm and environmental stress (Jensen and Proksch, 2009). The 
skin is composed of 3 main layers: the outer epidermis, the dermis, and the underlying 
subcutaneous tissue (Macneal, 2006). The epidermis is a stratified, squamous epithelium, 
which acts as the first line of defense against environmental insults, and regulates the 
diffusion of water and electrolytes (reviewed in Indra and Leid, 2011). The dermis is 
mainly comprised of fibroblasts and connective tissue that cushions the body from 
mechanical strain, and provides elasticity (reviewed in Haake et al., 2001). Finally, the 
inner subcutaneous tissue, or hypodermis, consists of a thick layer of adipose and 
connective tissues. The hypodermis is essential for the proper regulation of body 
temperature, energy storage, and can act as a shock absorber (Walters and Roberts, 
2002). 
1.1.1 The epidermis 
In humans, the epidermis is composed of 5 cell layers (reviewed in Haake et al., 2001; 
Figure 1.1). The innermost basal layer consists of basal keratinocytes that have a high 
proliferative capacity (Grinnel, 1992; Adams and Watt, 1989). Basal keratinocytes can be 
multipotent, epidermal stem cells that are responsible for the renewal capability of the 
epidermis  (Elias, 2007). There is a concentration gradient of extracellular Ca2+ across the  
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Figure 1.1. Layers of the epidermis.  
The epidermis is composed of 5 cell layers. The innermost layer, termed stratum basale, 
mainly consists of proliferating basal keratinocytes. These multipotent stem cells 
differentiate and move towards the outer layers of the skin to give rise to suprabasal 
layers  termed  spinous,  granular,   and  clear  cornified  epidermal  layers (Ivanova et al., 
2005). 
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epidermal layers, which induces basal keratinocytes to differentiate and move towards the 
outer layers of the epidermis, giving rise to suprabasal layers termed spinous, granular, 
and cornified epidermal layers (Ivanova et al, 2005; Figure 1.1). The stratum spinosum is 
immediately above the basal layer, and contains keratinocytes, as well as 
immunologically active Langerhans cells that, in the case of pathogen invasion, trigger 
immune responses at the site of infection (Elias, 2007). Next, the stratum granulosum and 
stratum lucidum reside over the spinous layer (Méhul et al., 2003). The stratum 
granulosum is a thin, flattened layer in which cells begin to lose their nuclei, whereas the 
stratum lucidum is an extra epidermal layer present only on the thick skins of the palms 
and soles of feet (reviewed in Siegenthaler, 2006). Finally, the outermost stratum 
corneum is mainly comprised of dead keratinocytes that are continuously shedding and 
being replaced (Méhul et al., 2003).  
1.2 Keratinocyte survival and programmed cell death 
A proper balance between keratinocyte survival and programmed cell death is necessary 
to maintain epidermal homeostasis (Raj et al., 2006). Older or damaged cells along the 
apical surface are constantly replaced (Pellettieri and Sanchez, 2007).  
1.2.1 Types of cell death 
According to the Nomenclature Committee on Cell Death (NCCD), various forms of cell 
death exist, which can be defined by a number of characteristics, including morphological 
appearance (apoptotic vs. necrotic), enzymatic activity (presence or absence of nucleases 
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and/or proteases), functional components (accidental or systematic), or immunological 
features (Kroemer et al., 2009). Until recently, criteria accepted in a “dying” cell included 
activation of cysteine-aspartic proteases (caspases), loss of mitochondrial transmembrane 
potential, and/or phosphatidylserine (PS) exposure in the outer leaflet of the plasma 
membrane (reviewed in Kroemer et al., 2009). The currently accepted criteria to 
distinguish a cell undergoing death from a viable one are: (1) the structural integrity of 
the plasma membrane has been lost, (2) the cell has been fragmented into apoptotic 
bodies, (3) the fragmented pieces have been phagocytosed by neighbouring cells 
(reviewed in Kroemer et al., 2009).  
Cell death can occur through a number of different processes based on the morphological 
properties of the dying cell (reviewed in Kroemer et al., 2009). Necrosis, more commonly 
known as death by cell injury or disease, is accompanied by a growth in cell volume, 
organelle swelling, and a loss of intracellular components due to rupturing of the cell 
membrane (reviewed in Kroemer et al., 2009). Apoptosis, on the other hand, is 
characterized by a reduction in cell volume, plasma membrane blebbing, chromatin 
condensation, DNA fragmentation, and rounding of the cell (reviewed in Kroemer et al., 
2009). In contrast to necrotic cell death, the integrity of cytoplasmic organelles is 
preserved in apoptotic cells, until they are engulfed by adjacent cells (reviewed in 
Kroemer et al., 2009). Thus, the features of a cell undergoing necrosis differ from those 
of a cell undergoing apoptosis. In the epidermis, cornification is yet another form of 
programmed cell that exclusively occurs in keratinocytes (Candi et al., 2005). 
Keratinocytes of the basal layer become differentiated as they move towards the cornified 
layer of the epidermis. This cornified envelope is comprised of dead keratinocytes, called 
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corneocytes, which have reached the terminal stage of epidermal differentiation (Candi et 
al., 2005). The amalgam of proteins, including keratins, loricrin, and involucrin, as well 
as lipids, present in corneocytes, allow the cornified layer to fulfill its function for water 
retention and the formation of an impermeable barrier (reviewed in Kroemer et al., 2009).  
1.2.2 Apoptosis in the epidermis 
Apoptosis, a highly regulated form of programmed cell death, is necessary for proper 
development and epidermal homeostasis (Raj et al., 2006). The dysregulation of 
apoptosis is a critical aspect of carcinogenesis (reviewed in Scatena et al., 2012). In the 
epidermis, apoptosis regulates tissue thickness, facilitates the turnover of newly 
synthesized tissue, and eliminates damaged or infected cells (Raj et al., 2006). As the first 
line of defense from the external environment, the epidermis is exposed to many insults, 
including ultraviolet (UV) radiation, oxidative stress, mechanical and chemical damage, 
and microbial infection (reviewed in Haake et al., 2001). Therefore, apoptosis is a key 
mechanism to eliminate damaged cells. 
1.2.3 Extrinsic vs. intrinsic apoptosis pathway 
Two main pathways for apoptotic cell death have been identified: the extrinsic and 
intrinsic pathway.  
The extrinsic apoptotic pathway is stimulated by proapoptotic, extracellular ligands that 
bind to their respective death receptors (reviewed in Ashkenazi, 2008; Figure 1.2). 
Proapoptotic receptors are members of the tumour necrosis factor (TNF) family 
(reviewed in Fulda and Debatin, 2006). The TNF superfamily consists of over 20 proteins 
7 
Figure 1.2. The extrinsic and intrinsic apoptosis pathway. 
The extrinsic apoptosis program is mediated by the binding of death ligands to their death 
receptors, which stimulates the cascade caspase via caspase-8 activation. The intrinsic 
apoptotic pathway is stimulated within the cell in response to signals resulting from 
cellular stress. Such stimuli then activate downstream caspases to induce apoptosis 
(reviewed in Fulda and Debatin, 2006). 
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involved in a variety of cellular functions, ranging from regulation of cell survival and 
cell death to immune responses (Walczak and Krammer, 2000). TNF death receptors are 
characterized by an 80 amino acid-long, cytoplasmic domain that has been designated the 
“death domain” (reviewed in Fulda and Debatin, 2006). The death domain plays a critical 
role in relaying extracellular signals from death ligands on the cell surface, to activate 
downstream signalling pathways within the cell (reviewed in Fulda and Debatin, 2006; 
Figure 1.2). Once they have been activated, the death receptors recruit the execution 
procaspases 8 and 10 as well as the Fas-associated death domain adaptor molecule to 
their death domains. Together, these molecules form the death-inducing signalling 
complex (DISC) (reviewed in Ashkenazi, 2008). These DISCs then stimulate the caspase 
cascade via cleavage and consequent activation of procaspases 8 and 10. Active caspases 
8 and 10, in turn, activate downstream effectors, such as caspase-3, 6, and 7, ultimately 
leading to apoptosis (Leblanc et al., 2002). In cultured keratinocytes, apoptosis triggered 
through UVB exposure is a result of the activity of pre-synthesized proteins, rather than 
de novo transcriptional processes (reviewed in Raj et al., 2006). Studies conducted on the 
human HaCaT keratinocyte cell line have demonstrated that caspase-8 becomes activated 
as a result of UVB-induced multimerization of the Fas death receptors (Takahashi et al., 
2001a).  
The intrinsic pathway, also known as the mitochondrial pathway, is stimulated from 
within the cell, often in response to signals resulting from DNA damage, loss of cell 
survival factors, or cellular stress (reviewed in Fulda and Debatin, 2006; Figure 1.2). In 
this pathway, the activation of downstream caspases is caused by permeabilization of the 
outer  membrane  of  mitochondria (Green and Kroemer, 2004). This process relies on the  
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Bcl-2 protein family, which is responsible for regulating mitochondrial membrane 
permeability. Bcl-2 proteins  determine whether a pro- or anti-apoptotic process will be 
activated. For example, Bax, Bak, and Bid promote, whereas Bcl-2 and Bcl-xl inhibit 
apoptosis (Wei et al., 2001). Bax and Bak are predominantly cytosolic. However, they 
translocate to the mitochondria in response to apoptotic stimuli, such as excessive DNA 
damage or elevated concentrations of free radical species (Wei et al., 2001). Once 
localized to the mitochondrial membrane, Bax and Bak form homo- and/or heterodimers 
to create the mitochondrial apoptosis-induced channel (MAC), which is responsible for 
the release of apoptogenic factors, such as cytochrome c, into the cytoplasm (reviewed in 
Fulda and Debatin, 2006). In the cytoplasm, cytochrome c interacts with apoptotic 
protease activating factor 1 (Apaf-1), to form an apoptosome (reviewed in Raj et al., 
2006; Figure 1.2).  The apoptosome then recruits and activates the initiator procaspase-9, 
which stimulates caspase-mediated apoptosis (Zou et al., 2003). The mitochondria can 
also activate the caspase program through the release of Smac/DIABLO, which interferes 
with the effects of apoptosis-inhibiting proteins (reviewed in Raj et al, 2006).  
The extrinsic and intrinsic apoptosis pathways are interdependently regulated. Although 
they differ in their modes of activation, there are a number of proteins involved in both 
processes. Specifically, caspase-3 and caspase-7 are shared targets of these two apoptosis 
programs (reviewed in Raj et al., 2006). The cleavage and subsequent activation of 
caspase-3 and caspase-7 are mediated extrinsically by caspase-8, and intrinsically by 
caspase-9 (reviewed in Raj et al., 2006). The enzymatic properties of these executioner 
caspases lead to the cleavage of downstream proteins that are involved in DNA repair and 
the structural stability of the cytoskeleton and nuclear membrane (reviewed in Raj et al., 
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2006). Ultimately, the protease activity of these terminal caspases is responsible for the 
disassembly and degradation of the cell.  
Both the intrinsic and extrinsic apoptosis pathways are activated in keratinocytes by a 
diverse array of stress stimuli, including UV exposure, heat shock, oxidative stress, and 
exposure to cytotoxic chemicals (reviewed in Raj et al., 2006). The detrimental effects 
that arise due to UV-induced apoptosis appear to be of a synergistic combination of 
pathways activated in response to damaged DNA, activation of death receptors, and the 
formation of reactive oxygen species (ROS) (Kulms et al., 1999; Kulms et al., 2002). UV 
radiation is the primary cause of most skin cancers, and elicits its effects in the absence of 
any specific tumour promoter, making it a potent and dangerous carcinogen (reviewed in 
Assefa et al., 2005). UV-induced skin cancer is characterized by irreversible DNA 
damage, and the release of harmful photoproducts. Any unrepaired DNA can lead to 
mutations in both oncogenes and/or tumour suppressor genes, and subsequent tumour 
development (reviewed in Assefa et al., 2005).  
1.3 Reactive oxygen species 
Free radical species are molecules that bear one or more unpaired electrons (Halliwell 
and Gutridge, 1989). “ROS” is a generalized term used to describe both oxygen radicals, 
such as peroxyl (RO2!), hydroxyl (OH!), and superoxide (O2
-!) radicals, as well as some 
nonradical oxidizing compounds (reviewed in Bayir, 2005). Such oxidizing agents 
include hydrogen peroxide (H2O2), which can be readily converted into reactive radical 
12 
species (reviewed in Bayir, 2005). Although they are typically associated with deleterious 
effects, ROS are actually generated as a normal biproduct of oxidative metabolism 
(reviewed in Bayir, 2005). In particular, they are involved in cellular processes such as 
electron transport in the mitochondria, enzymatic reactions, signal transduction, and 
immunological responses against microbial threats (reviewed in Bayir, 2005). Growth 
factors and cytokines can stimulate increases in ROS production, necessary for various 
cellular processes (reviewed in Simm and Brömme et al., 2005). For example, in vascular 
smooth muscle cells, the presence of H2O2 is essential for functional tyrosine 
phosphorylation and proper DNA synthesis stimulated by platelet-derived growth factor 
(PDGF) (Sundaresan et al., 1995). In addition, the ERK and the pro-survival phosphatidyl 
3-kinase/Akt pathways can be activated through various growth factor receptors in 
response to oxidizing agents (reviewed in Simm and Brömme et al., 2005). At the level of 
transcription, ROS are also involved in the activation of the pro-survival, NF-kB 
pathway, which is involved in the inflammatory response of the skin (reviewed in Bickers 
and Athar, 2006). In human T-cell and murine fibrosarcoma cell lines, NF-kB can be 
activated by H2O2, either through the degradation of the NF-kB inhibitor, IkB, or by 
preventing NF-kB association with DNA via oxidation of its DNA-binding domain 
(Schreck et al., 1991; Schenk et al., 1993). Finally, in mouse fibroblasts, ROS production 
by NADPH-oxidases is stimulated as a defense response to microbial infections or to 
pathogens invading the cells (Taddei et al., 2007). Thus, despite the destructive nature of 
oxidative radicals, a moderate level of ROS is necessary for proper cellular signalling and 
function. 
13 
1.3.1 Sources of ROS 
In mammalian cells, ROS are produced as a result of both enzymatic and nonenzymatic 
processes (reviewed in Bayir, 2005). In particular, the catalytic activity of certain 
enzymes, including nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, 
contributes to the formation of free radical species (reviewed in Bayir 2005). NADPH 
oxidase is a membrane-bound enzymatic complex that uses NADPH-supplied electrons 
to produce O2
-! from oxygen (reviewed in Bayir, 2005). NADPH oxidase is activated in 
leukocytes in response to inflammatory stimuli (reviewed in Bayir, 2005), leading to a 
vast production of O2
-!, which provides leukocytes with the ability to eliminate 
microorganisms (Vignais, 2002). In addition to endogenous sources, ROS can also be 
generated through exogenous oxidizing agents, such as chemicals, environmental 
pollutants, cigarette smoke, xenobiotics, and UV radiation (reviewed in Vallyathan and 
Shi, 1997). Ultimately, excessive endogenous and/or exogenous ROS can have damaging 
effects on the cell. 
1.3.2 ROS in keratinocytes 
Epidermal keratinocytes must be able to cope with external ROS-generating stressors, 
such as UV radiation and oxygen (reviewed in Bito and Nishigori, 2012). On one hand, 
ROS can be beneficial through their role in signalling processes. Findings by Huang et al. 
(2001) demonstrated that in epidermal cells, the phosphorylation and activation of protein 
kinase B (Akt) could be induced by H2O2 in a dose-dependent fashion. Similarly through 
in vivo studies, Bito et al. (2010) showed that ROS play a direct role in the signal 
transduction of keratinocytes. On the other hand, UVB photons from the sun are 
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particularly detrimental to keratinocytes, causing damage to DNA through the generation 
of reactive (6-4) photoproducts, pyrimidine dimers (Mitchell et al., 1992), and hydroxy-
2’-deoxyguanosine (Hattori et al., 1996). The formation of these oxidative radicals 
accounts for approximately 50% of the damage produced by UV radiation (reviewed in 
Bito and Nishigori, 2012).  
Under normal circumstances, the epidermis is able to withstand oxidative stress because 
keratinocytes produce sufficient antioxidants to protect and buffer the harmful effects of 
radical species (reviewed in Bito and Nishigori, 2012). Keratinocytes contain a 
physiological threshold of antioxidants, such as α-tocopherol (VE), ascorbic acid (VC), 
and glutathione (GSH), which act to scavenge oxidative radicals. Other contributions to 
ROS scavenging are superoxide dismutase, which converts O2
-! to H2O2 and O2, as well 
as catalase and glutathione peroxidase, which reduce H2O2 to H2O and O2 in peroxisomes 
and mitochondria, respectively (Matés, 2000). However, when the amount of oxidative 
stress exceeds the cell’s capacity to quench ROS, substantial DNA damage can occur 
(reviewed in Assefa et al., 2005). If the cell damage is not too extensive, a variety of 
repair programs are activated, namely the base excision repair (BER) and nucleotide 
excision repair pathways (reviewed in Lu et al., 2001). BER involves DNA glycosylases, 
which eliminate improper base incorporations into DNA (reviewed in Lu et al., 2001). In 
the epidermis, the overproduction of cellular ROS acts to reduce endogenous levels of 
antioxidants, including the aforementioned VE, VC, and GSH (Hanada et al., 1997). By 
disrupting the intracellular redox balance, the repair ability and reducing properties of the 
cell become compromised. Thus, cells become even more susceptible to the detrimental 
effects of oxidative stress. Therefore, the redox potential of keratinocytes is critical for 
15 
reducing intracellular ROS levels, and to prevent excessive damage and cell death 
(reviewed in Bito and Nishigori, 2012).  
1.3.3 Stress-induced apoptosis 
Depending on the nature and extent of stressors received by a cell, the extrinsic and/or 
intrinsic apoptosis pathway can be activated. The mitogen-activated protein kinases 
(MAPKs) are a group of enzymes frequently involved in stress-induced apoptosis 
through extrinsic and intrinsic programs (reviewed in Bito and Nishigori, 2012; Kyriakis 
et al., 1994). In particular, UVB-induced apoptosis in keratinocytes is associated with 
increased phosphorylation and activation of c-Jun N-terminal kinase (JNK) and p38 
(Shimizu et al., 1999; Van Laethem et al., 2006). The activation by ROS of JNK and p38 
are well established in many cell types (Shiah et al., 1999; Benhar et al., 2001; El-Najjar 
et al., 2010). Interestingly, the response of another MAPK protein, extracellular signal-
regulated kinase (ERK) appears to have contrasting effects with respect to ROS, 
depending on the cell type (Xia et al., 1995; Tan and Chiu, 2013). However, in 
keratinocytes, ERK is activated by H2O2 through transforming growth factor-β1 (TGF-
β1) (Kim et al., 2006). Studies have demonstrated that ROS stimulates TGF-β1 signalling 
pathways that lead to the activation of ERK. ERK stimulation then induces the apoptotic 
programs associated with the terminal differentiation processes of keratinocytes (Kim et 
al., 2006; Iglesias et al., 2000). Significantly, the activation of these MAPKs stimulates 
Bax translocation to the outer mitochondrial membrane, activating apoptosis programs 
(Van Laethem et al., 2004). 
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In keratinocytes, stress-induced signals are often mediated by different transmembrane 
protein receptors to induce cell growth, adhesion or apoptosis (reviewed in Taddei et al., 
2007). Integrins, in particular, are a family of transmembrane proteins that participate in 
transducing extracellular signals into the cell (Zeller et al., 2013). Recently, it has been 
proposed that ROS production, commonly associated with microbial infection or 
apoptosis execution, can also stimulate the same enzymatic reactions linked to the redox-
dependent processes during integrin signal transduction (Taddei et al., 2007; Zeller et al., 
2013). Specifically, mitochondrial ROS generation has been associated with the early 
stages of cell-ECM adhesion through integrins (Taddei et al., 2007). Thus, cells likely 
require a threshold level of ROS for cell attachment and spreading, in addition to 
programmed cell death. 
1.4 Integrins 
Integrins are heterodimeric, transmembrane proteins that link the actin cytoskeleton with 
the extracellular matrix (reviewed in Hynes, 2002). In mammals, the integrin family is 
composed of 18 α- and 8 β-subunits that make up 24 heterodimeric members (reviewed 
in van der Flier and Sonnenberg, 2001). Targeted inactivation of genes encoding integrins 
leads to a wide array of defects, ranging from subtle phenotypic abnormalities to lethality 
(van der Flier and Sonnenberg, 2001).  
In the epidermis, integrins have been categorized into β1-containing, αv-containing, and 
α6β4 integrins (reviewed in Margadant et al., 2010). These three types of integrins are 
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constitutively expressed, whereas other classes are induced during wound healing 
(reviewed in Margadant et al., 2010). The α2β1 and α3β1 integrins modulate the actin 
cytoskeleton through focal adhesion proteins, such as talin and vinculin (reviewed in 
Watt, 2002; reviewed in Margadant et al., 2010). Integrins containing the α5 subunit, 
such as αvβ5 and αvβ8, predominantly bind to vitronectin and are expressed at low levels 
in intact adult epidermis (reviewed in Margadant et al., 2010). Finally, α6β4 integrins 
bind to laminin and are critical for basal keratinocytes adhesion to the basement 
membrane at the dermal-epidermal junction (reviewed in Margadant et al., 2010). 
Apart from their role in cell-ECM adhesion, integrins act as signalling modulators in the 
epidermis. Specifically, they interact with focal adhesion kinase (FAK), kindlins, and 
integrin-linked kinase (ILK) (reviewed in Margadant et al., 2010). A primary function of 
FAK is to stimulate signalling events at focal adhesions (Ilić et al., 1995). FAK-deficient 
mice display defects in the hair cycle, but no abnormalities in the integrity of the 
epidermis, suggesting that FAK may be involved in the integrin-related pathways 
downstream or independent of cellular adhesion (Essayem et al., 2006). Similarly, the 
kindlin family of adaptor proteins is involved in the activation of integrins (Meves et al., 
2009). Finally, integrins associate with another adaptor scaffold protein termed ILK. 
Previous findings have established a role for the direct integrin-ILK interaction in 
reinforcing the cytoskeletal support of the cell through indirect association with actin via 
particularly interesting new cysteine-histidine-rich protein (PINCH) and parvin (Legate et 
al., 2006).  
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1.4.1 Integrins and epidermal homeostasis 
In the epidermis, integrins are involved in maintaining homeostasis through their roles in 
keratinocyte adhesion, proliferation, differentiation, and survival (reviewed in Margadant 
et al., 2010). α6β4 integrin mediates the adhesion of basal keratinocytes to the basement 
membrane, although their role in keratinocyte proliferation and survival remains 
unresolved (reviewed in Margadant et al, 2010). Integrin-mediated signals are necessary 
to inhibit apoptosis by promoting the pro-survival PI3-kinase/Akt pathway and 
stimulating cell cycle progression through the ERK pathway (Hynes, 2002). Further, a 
reduction in the fraction of proliferating cells in the epidermis of mice expressing a 
mutant β4 integrins has been reported (reviewed in Margadant et al., 2010). Mice lacking 
expression of integrin α3 and/or integrin α6 display a severe blistering phenotype, likely 
as a result of impaired epidermal integrity due to keratinocyte detachment (reviewed in 
Margadant et al., 2010). Mice with conditional inactivation of the gene encoding integrin 
β1 exhibit a plethora of phenotypic defects, including blistering, reduced proliferative 
capacity, abnormalities of the basement membrane, epidermal inflammation, and hair 
loss (reviewed in Margadant et al., 2010).  
1.5 Integrin-linked kinase 
ILK is a ubiquitous adaptor protein that binds to integrins (Hannigan et al., 1996). ILK 
functions as a scaffold between the cytoplasmic domain of β1 or β3 integrins and the 
actin cytoskeleton (Hannigan et al., 1996). 
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ILK is composed of three main domains (Chiswell et al., 2008; Figure 1.3). It has five N-
terminal ankyrin repeats, which mediate binding to PINCH. ILK-PINCH complexes are 
critical for the localization of ILK to focal adhesions (Wu, 1999; Figure 1.4).  ILK also 
has a pleckstrin-homology-like domain that indirectly associates with phosphoinositides, 
which are involved in cell growth, cell survival, and protein trafficking (reviewed in 
Hannigan et al., 2005). Finally, its C-terminal kinase-like domain is responsible for the 
interaction of ILK with many proteins, including paxillin and parvins (reviewed in Qin & 
Wu, 2012). The association of ILK with the parvin family is responsible for its 
involvement in focal adhesions at the cell surface (Tu et al., 2001; Yamaji et al., 2001).  
1.5.1 ILK as a pseudokinase 
The kinase properties of ILK have long been debated. A key source of the conflicting 
notion that ILK possesses kinase activity stems from the high degree of homology 
between the amino acid sequence of ILK to that of bona fide serine-threonine kinases 
(Maydan et al., 2010). However, although sequencing of the kinase-like, C-terminus of 
ILK shares homology with other kinases, the lack of catalytic activity can be attributed to 
the divergence in 3D structural configuration (reviewed in Dagnino, 2011). Whereas ILK 
shares an APE moiety and ATP-binding lysine residue with other serine-threonine 
kinases, it lacks DFG and HRD motifs conserved in most kinases (Maydan et al., 2010). 
Thus, despite its ability to bind ATP, ILK lacks essential kinase function, as its kinase-
like domain does not directly catalyze ATP hydrolysis (Fukuda et al., 2009).  
In vitro studies to determine the kinase properties of ILK have also generated contrasting 
results.  A   GST-ILK  fusion  protein  purified  from  bacteria  was  previously  shown  to  
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Figure 1.3. ILK protein domains.  
ILK is composed of three distinct domains: an N-terminus consisting of 5 ankyrin 
repeats, a pleckstrin homology-like (PH) domain, and a C-terminus kinase-like domain 
(Chiswell et al., 2008). 
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Figure 1.4. ILK signalling pathway.  
ILK is involved in a number of cellular processes including cell-ECM adhesion via 
integrins, F-actin dynamics and cell polarity via Rac1, parvins, and ELMO2, and cell 
survival via Akt activation.  
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phosphorylate certain substrates, including myelin basic protein (Hannigan et al., 1996). 
In spite of this, Fukuda et al. (2009) demonstrated that neither a bacterially produced nor 
a commercial, recombinant form of ILK elicited any kinase activity. Further, the 
expression of ILK mutant ILK E359K (which possesses no “kinase” properties) does not 
alter the phosphorylation of its reported substrates, Akt and glycogen synthase kinase- 3β 
(GSK-3β), in immortalized kidney fibroblasts and chrondrocytes (Sakai et al., 2003; 
Grashoff et al., 2003). However, conflicting findings of ILK in its modulation of Akt 
phosphorylation in HEK 293 human embryonic kidney cells and Schwann cells have 
suggested a cell type-specific response (Delcommenne et al., 1998; Pereira et al., 2009). 
Experiments conducted in vivo have also supported the notion of a dispensable “kinase” 
domain of ILK. Zervas et al. (2001) showed that embryonic lethality consequent to the 
absence of ILK in Drosophila melanogaster embryos could be rescued through the 
introduction of the ILK E359K mutant. Embryos expressing E359K or wild-type ILK 
were phenotypically indistinguishable. Similarly in Caenorhabditis elegans deficient in 
ILK, Mackinnon et al. (2002) demonstrated that ILK E359K expression could restore the 
associated defects in muscle assembly. 
A study conducted by Lange et al. (2009) involved the generation of point mutations of 
the Ilk gene that were predicted to impair any kinase activity ILK may elicit. However, 
mice expressing these mutants in the absence of wild type ILK exhibited no phenotypic 
defects (Lange et al., 2009). Additionally, epidermal keratinocytes isolated from mice 
expressing these ILK mutant proteins displayed normal adhesion, spreading, and actin 
cytoskeleton (Lange et al., 2009). Thus, the findings from this study suggest that ILK 
functions as a pseudokinase in epidermal keratinocytes. 
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1.5.2 ILK in different cell types 
ILK has some distinct functions in different cell types. Deng et al. (2001) demonstrated 
that ILK is involved in mediating smooth muscle contraction through myosin 
phosphorylation. Chondrocyte-specific inactivation of the Ilk gene leads to perinatal 
death in mice due to respiratory defects (Grashoff et al., 2003). These mice also develop 
chondrodysplasia that leads to irregularities in chondrocyte morphology and reduced 
proliferation (Grashoff et al., 2003). ILK-deficient embryos fail to implant as a result of 
impaired polarization of the epiblast, leading to lethality at the peri-implantation stage 
(Sakai et al., 2003). Specifically in the dermal layer of the skin, ILK-deficient fibroblasts 
also experience defects in their ability to spread and a delayed formation of focal 
adhesions (Sakai et al., 2003). Recent work conducted in our laboratory has also 
demonstrated a critical role for ILK in transducing signals necessary for proper dermal 
fibroblasts to myobroblast transition – a process essential for proper skin repair after 
injury (Vi et al., 2011). 
1.5.3 ILK in the epidermis 
Studies conducted in our laboratory have shown that ILK modulates polarity in 
keratinocytes through its interaction with Engulfment and Cell Motility 2 (ELMO2) (Ho 
et al., 2009). This ILK-ELMO2 complex has been shown to direct keratinocyte migration 
and lamellapodia formation through RhoG activity (Ho and Dagnino, 2011; Figure 1.4). 
Additionally, ILK has been found to play a critical role in the phagocytic capacity of 
keratinocytes (Sayedyahossein et al., 2012). ILK-deficient cells exhibit defects in their 
capacity for engulfment that can likely be attributed to an impaired activation of Rac1 
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(Sayedyahossein et al., 2012). We have also shown that in the absence of ILK, wound 
healing is impaired due to abnormal transformation growth factor-β signalling in dermal 
fibroblasts (Vi et al., 2011). Recent work in our laboratory has focused on the role of ILK 
in maintaining epidermal function. Nakrieko et al. (2008) demonstrated that Ilk gene 
inactivation in the epidermis of mice is associated with impaired hair follicle 
morphogenesis and polarized keratinocyte motility. Histologically, these ILK-deficient 
mice display many phenotypic defects, including reduced adhesion to the basement 
membrane, compromised epidermal integrity, perinatal death, and failure to thrive 
(Nakrieko et al., 2008). In addition, Ilk gene inactivation in the stem cell population of 
hair follicle bulges results in defective wound healing as well as a reduced contribution of 
stem cell progeny to the regenerating epidermis after injury (Nakrieko et al., 2011). Thus, 
ILK is involved in many aspects of skin function. 
1.5.4 The role of ILK in cell survival 
ILK promotes survival of various cell types (Bock-Marquette et al., 2004; Delcommenne 
et al., 1998). In primary neonatal cardiomyocytes, thymosin β4, an actin sequestering 
protein, forms a complex with ILK and PINCH to initiate a pro-survival pathway through 
Akt activation (Bock-Marquette et al., 2004). Similarly in IEC-18 intestinal epithelial 
cells, ILK promotes cell survival and inhibits apoptosis through the phosphoinositide-3-
OH kinase-dependent activation of GSK-3β and Akt (Delcommenne et al., 1998). 
Additionally, the loss of ILK in mouse hepatocytes leads to abnormal levels of apoptosis, 
as well as hepatitis (Gkretsi et al., 2007). Finally in SCP2 mouse mammary epithelial 
cells and breast cancer cell lines, ILK suppresses anoikis and promotes cell survival 
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through Akt activation (Attwell et al., 2000; Troussard et al., 2006). However, despite the 
established role of ILK in cell survival in the above-mentioned cell types, its role in 
keratinocyte survival remains unknown. 
1.6 Rationale and hypothesis 
Previous findings in our laboratory have demonstrated an essential role of ILK in 
maintaining epidermal integrity and function (Nakrieko et al., 2008). Mice with Ilk 
epidermis-restricted gene inactivation display severe phenotypic defects including 
impaired hair follicle morphogenesis, reduced adhesion to the basement membrane, 
failure to thrive, and perinatal death (Nakrieko et al., 2008). Apart from its adaptor 
scaffolding function, ILK has recently been found to play a substantial role in 
suppressing anoikis and apoptosis in various epithelial cell types (Benoit et al., 2007; 
Attwell et al., 2000). However, specific aspects of how ILK-insufficiency leads to 
impaired epidermal integrity are poorly understood. Based on observations of our ILK-
deficient mice, ILK appears to play a critical modulatory role in maintaining normal 
keratinocyte survival and retaining proper epidermal function. In addition to histological 
defects detected in the epidermis, we have consistently observed phenotypic 
abnormalities that resemble cells undergoing apoptosis in keratinocytes with Ilk gene 
inactivation. Thus, the aforementioned findings led me to hypothesize that ILK is 
required to maintain keratinocyte viability. To test my hypothesis, my specific aims were 
as follows: 
1. To determine the role of ILK in keratinocyte viability.
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2. To identify the mechanisms whereby ILK contributes to keratinocyte survival. 
 
Chapter 2 – Materials and Methods 
2.1 Reagents 
Reagents and their sources are shown in Table 1. 
Table 1: Reagents 
Reagent Source Catalogue No. 
Amersham ECL Prime Western 
blotting detection reagent 
GE Healthcare, Mississauga, ON RPN2232 
Aprotinin Bioshop, Burlington, ON APR200 
Bradford protein quantification 
solution 
Bio-Rad, Mississauga, ON 500-0006 
Ca2+-free Eagle’s minimum 
essential medium (EMEM) 
Lonza, Walkersville, MD 06-174G 
Chelex 100 resin Bio-Rad, Mississauga, ON 142-2842 
Cholera toxin List Biological Laboratories Inc, 
Burlington, ON 
100 
2’-7’-Dichlorofluorescein 
diacetate (DCFDA) 
Calbiochem (EMD Millipore), 
Billerica, MA 
4091-99-0 
Epidermal growth factor (EGF) Sigma, St. Louis, MO E4127 
FBS for keratinocytes Lonza, Walkersville, MD 14-561F 
Fetal bovine serum (FBS) Gibco, Burlington, ON 12483 
Hoeschst 33342 Life Technologies, Burlington, ON H1399 
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Reagent Source Catalogue No. 
Hydrocortisone Sigma, St. Louis, MO H4001 
Immu-mount mounting medium Thermo Scientific, Pittsburgh, PA 9990402 
Insulin Sigma, St. Louis, MO I6634 
Leupeptin Bioshop, Burlington, ON LEU001 
N-Acetyl-L-cysteine Sigma, St. Louis, MO A9165 
NaF Sigma, St. Louis, MO S7920 
Na3VO4 Bioshop, Burlington, ON SOV664 
Paraformaldehyde (PFA) Fisher Scientific, Whitby, ON AC416780030 
Penicillin (10,000 U/ml) and 
streptomycin (10 mg/ml) 
solution   
Gibco, Burlington, ON 15140 
Pepstatin Bioshop, Burlington, ON PEP605 
Phenylmethylsulfonylfluoride 
(PMSF)  
Bioshop, Burlington, ON PMS123 
Phospho Safe extraction reagent Novagen, San Diego, CA 71296-3 
Proteinase K Life Technologies, Burlington, ON AM2542 
Rat tail collagen I BD Biosciences, Bedford, MA 354236 
Triiodothyronine (T3) Sigma, St. Louis, MO T6397 
Triton X-100 EMD, Darmstadt, Germany CATX 1568 
2.5% trypsin Gibco, Burlington, ON 15090-046 
0.25% trypsin/0.9 mM 
ethylenediaminetetraacetic acid 
(EDTA) 
Gibco, Burlington, ON 25200-056 
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2.2 Antibodies 
Antibodies, their sources, and working dilutions are shown in Table 2. 
Table 2: Antibodies 
Antibody Source Catalogue 
No. 
Dilutiona 
Bax (N-20) Santa Cruz Biotechnology, Santa 
Cruz, CA 
sc-493 1:150 (IF) 
5-bromo-2’-
deoxyuridine 
(BrdU) 
Developmental Studies Hybridoma 
Bank, Iowa City, IA 
N/A 1:1000 (IF) 
Cleaved Caspase-3 Cell Signalling, Pickering, ON 9661 1:1000 (IB) 
Cleaved PARP 
(Poly ADP Ribose 
Polymerase) 
Cell Signalling, Pickering, ON 9544 1:1000 (IB) 
Glyceraldehyde 3-
phosphoate 
dehydrogenase 
(GAPDH) 
Assay Designs, Ann Arbor, MI CSA-335 1:5000 (IB) 
MTCO1 [1D6E1A8] Abcam, Cambridge, MA ab14705 1:50 (IF) 
Phospho-Akt 
(Thr308) 
Cell Signalling, Pickering, ON 9275 1:1000 (IB) 
Akt Cell Signalling, Pickering, ON 9272 1:1000 (IB) 
Phospho-histone 
H2A.X (Ser139) 
(γH2A.X) 
Cell Signalling, Pickering, ON 9718 1:1000 (IB) 
1:200 (IF) 
Phospho-p44/42 
MAPK 
(Thr202/Tyr204) 
(D13.14.4E) 
Cell Signalling, Pickering, ON 4370 1:1000 (IB) 
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Antibody Source Catalogue 
No. 
Dilutiona 
p44/42 MAPK 
(Erk1/2) 
Cell Signalling, Pickering, ON 9102 1:1000 (IB) 
Phospho-
SAPK/JNK 
(Thr183/Tyr185) 
(81E11) 
Cell Signalling, Pickering, ON 4668 1:1000 (IB) 
SAPK/JNK Cell Signalling, Pickering, ON 9252 1:1000 (IB) 
ILK BD Transduction Laboratories, 
Lexington, KY 
611802 1:5000 (IB) 
γ-tubulin Sigma, St. Louis, MO T6557 1:150 (IB) 
HRP-conjugated 
goat anti-mouse IgG 
Jackson ImmunoResearch, West 
Grove, PA 
115-038-
003 
1:500 (IB) 
HRP-conjugated 
goat anti-rabbit IgG 
Cell Signalling, Pickering, ON 7074 1:500 (IB) 
AlexaFluorTM 488 -
conjugated goat 
anti-mouse IgG 
Molecular Probes/Invitrogen, 
Eugene, OR 
A11001 1:5000 (IF) 
AlexaFluorTM 488 -
conjugated goat 
anti-rabbit IgG 
Molecular Probes/Invitrogen, 
Eugene, OR 
A11008 1:5000 (IF) 
AlexaFluorTM 594 -
conjugated goat 
anti-mouse IgG  
Molecular Probes/Invitrogen, 
Eugene, OR 
A11005 1:5000 (IF) 
AlexaFluorTM 594 -
conjugated goat 
anti-rabbit IgG 
Molecular Probes/Invitrogen, 
Eugene, OR 
A11012 1:5000 (IF) 
2.3 Mouse strains and genotyping 
Mice with epidermis-restricted inactivation of the Ilk gene have been generated in our 
laboratory, and previously described (Nakrieko et al., 2008). These mice are generated by 
a IF = Immunofluorescence
 IB = Immunoblot
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breeding Ilktm1Star mice, in which exons 4 and 12 of the Ilk allele are flanked by lox P sites 
(hereafter termed Ilkf/f; ref. 17) and Tg(KRT14-cre)1Amc/J mice (hereafter termed 
K14Cre; stock no. 004782; Jackson Laboratory; ref. 18). In this manner, we have mice 
that express Ilk in the epidermis (K14Cre+/-;Ilkf/+), and ILK-deficient littermates 
(K14Cre+/-;Ilkf/f). 
To determine the genotypes of mice in each litter, genomic DNA was isolated from tail 
clippings (1-2 mm in length), obtained at the time of skin harvesting (please see Section 
2.4). The tails were placed in microcentrifuge tubes, and digested with 100 µl of P-K 
buffer (20 mM Tris Cl pH 8.3, 50 mM KCl, 2.5 mM MgCl2, 0.5% Tween-20) containing 
6 µl of Proteinase K stock (20 mg/ml). The samples were incubated in a thermomixer at 
58°C with shaking at 3,000 rpm for 3-16 hours. The digested tissue solution was mixed 
by vortexing, and then heated to 95°C in a thermomixer with shaking (3,000 rpm) for 15 
minutes. Digested tissue samples were diluted 1:10 with HPLC-grade water (Fischer, 
Catalogue No. W5-1), and used as templates for polymerase chain reaction (PCR) 
amplification. PCR amplification was conducted for 34 cycles (94°C for 45 seconds; 
55°C for 30 seconds, 72°C for 45 seconds), using Taq DNA Polymerase kits (Qiagen, 
Catalogue No. 201205) and the appropriate primers. Cre transgene amplicons were 
obtained using a multiplex assay, with primer sets specific for Cre mixed with primers 
specific for the Cpxm1 gene (Institut Clinique de la Souris; http://www.ics-
mci.fr/mousecre/pdf/standard_cre_genotyping.pdf). The primer sequences are: Ilk, 
forward: 5'-CTGTTGCAATACAAGGCTGAC-3', reverse: 5'-
CTCGGAGAAGCTCTCTAAGGGG-3'; Cre, forward: 5’-
CCATCTGCCACCAGCCAG-3’, reverse: 5’TCGCCATCTTCCAGCAGG-3’; Cpxm1, 
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forward: 5’-ACTGGGATCTTCGAACTCTTTGGAC-3’, reverse: 5’-
GATGTTGGGGCACTGCTCATTCACC-3’. Amplicons were resolved on 3% agarose 
gels, and gel images were obtained with an AlphaImager 1220 Version 5.5 
(ProteinSimple). Amplicon sizes were 360 bp for the wild type Ilk allele, 380 bp for the 
floxed Ilk allele, 281 bp for Cre, and 420 bp for Cpxm1. 
 
2.4 Isolation and culture of primary mouse epidermal 
keratinocytes 
Three-day-old K14Cre+/-;Ilkf/+ and K14Cre+/-;Ilkf/f littermates were euthanized by CO2 
inhalation, and skins were harvested as described (Dagnino et al., 2010; Ho et al., 2009). 
Following euthanasia, mice were immersed for 15 minutes in 70% isopropanol at room 
temperature. The skins were harvested and each skin was placed dermis-side down in a 
well of a 6-well plate containing 2 ml of freshly diluted 0.25% trypsin. The skins were 
incubated at 4°C for 16 hours. Concurrently, tail clippings for genotyping were isolated. 
After determining the genotype of each skin, the trypsin was removed by aspiration, and 
replaced with fresh 0.25% trypsin. The skins were then incubated at 37°C for 20 minutes. 
The epidermis was mechanically separated from the dermis using forceps, placed into 50-
ml FalconTM conical tubes (BD, Catalogue No. 352098) containing keratinocyte growth 
medium (Ca2+-free EMEM supplemented with 8% Chelex resin-treated fetal bovine 
serum (FBS), 100 U/ml penicillin, 100 µg/ml streptomycin, 74 ng/ml hydrocortisone, 5 
µg/ml insulin, 9.5 ng/ml cholera toxin, 5 ng/ml epidermal growth factor (EGF), and 6.7 
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ng/ml triiodothyronine (T3)), and minced with scissors. The epidermis fragments were 
gently rocked in a tissue culture incubator at 37°C for 20 minutes to obtain a cell 
suspension. The latter was filtered through 70-µm pore size FalconTM cell strainers (BD, 
Catalogue No. 352350) to remove cornified envelope fragments. Trypan blue-excluding, 
viable cells were counted on a haemocytometer. The cells were plated onto 60- or 100-
mm PrimariaTM culture dishes (Corning, Catalogue No. 734-0071; 734-0072, 
respectively) at a density of 3x106 cells/21 cm2 or 7.5x106 cells/58 cm2 for K14Cre+/-
;Ilkf/+ keratinocytes, or 3.5x106 cells/21 cm2 or 9x106 cells/58 cm2 for K14Cre+/-;Ilkf/f 
keratinocytes. After 24 hours, the growth medium was replaced, and medium changes 
were subsequently conducted every 48 hours. Keratinocytes were cultured at 37°C in a 
humidified atmosphere containing 5% CO2. All experiments were conducted on 
keratinocytes that had been cultured for 48-72 hours, and that had reached 70-80% 
confluence.  
Where indicated, cells were cultured in Ca2+-free EMEM supplemented only with fetal 
bovine serum (FBS), without FBS but with hydrocortisone, insulin, cholera toxin, EGF, 
and T3 (HICE T3), or supplemented only with 25 µM bovine serum albumin (BSA).  
For experiments containing H2O2 treatments, a stock of 50 mM H2O2 was originally 
diluted from commercially available 30% H2O2 diluted in phosphate buffered saline 
(PBS), and sterilized by filtration through 0.2-µm pore size filters prior to use. Working 
H2O2 dilutions were then prepared using culture medium, immediately before use.  
For experiments involving treatment with N-Acetyl-L-cysteine (NAC), this chemical was 
diluted in sterile PBS to a final concentration of 125 mM, and 1 M NaOH was used to 
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adjust the pH to 7.4. The NAC solution was sterilized by filtration through a 0.2-µm pore 
size filter prior to addition to cell cultures. 
2.5 Measurement of cell proliferation 
Keratinocytes isolated from Ilkf/f, K14Cre+/-;Ilkf/+, or K14Cre+/-;Ilkf/f epidermis were 
plated at 2x105 cells/2 cm2. At timed intervals after plating, cells were washed once with 
PBS and incubated with 200 µl of 0.25% trypsin-EDTA for 5-10 minutes at 37°C. The 
detached cells were collected and an equal volume of 0.5% trypan blue dye was added to 
each sample. Trypan-blue excluding cells were counted on a haemocytometer. 
2.6 Measurement of DNA synthesis 
Primary mouse keratinocytes were plated in 24-well culture dishes at 2.5x105 cells/2 cm2. 
At timed intervals after plating, cells were incubated in growth medium containing 10 
µM bromodeoxyuridine (BrdU) for 2 hours at 37°C. The cells were fixed, permeabilized, 
and washed as described in Section 2.11. Nuclear DNA was denatured by incubating with 
2 M HCl for 20 minutes at 22°C. The samples were thoroughly washed five times with 
PBS, for 10 minutes each wash, and incubated with anti-BrdU antibody, with gentle 
rocking for 2 hours at 22°C, or for 16 hours at 4°C. Incubation with primary antibody 
was followed by washes and incubation with AlexaFluorTM-conjugated goat anti-mouse 
antibodies. The samples were washed and mounted as described Section 2.11.  
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2.7 Apoptosis measurements 
Apoptosis was measured using Cell Death Detection ELISA kits (Roche, Catalogue No. 
11544675001), following the manufacturer’s instructions. K14Cre+/-;Ilkf/+ and         
K14Cre+/-;Ilkf/f keratinocytes were plated at a density of 1x105 cells/2 cm2 on a 24-well 
plate. Twenty-four hours after plating, the cells were washed once with sterile PBS and 
the growth medium was replaced with treatment media (Complete, FBS, HICET3, or 
BSA). Cells were cultured for 16 hours at 37°C. The cells were washed with sterile PBS 
and then lysed using a modified RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 
1% NP-40, 0.5% sodium deoxycholate, 1 mM PMSF, 10 mM Na3VO4, 1 µg/ml NaF, 1 
µg/ml aprotinin, 1 µg/ml pepstatin, 1 µg/ml leupeptin) for 40 minutes on ice. Triplicate, 
20-µl samples of each lysate were added to the 96-well streptavidin-coated microplate 
provided in the kit. Next, 80 µl of a solution containing anti-DNA-peroxidase and anti-
histone-biotin was transferred to each well and incubated for 90 minutes at 22°C. Cells 
were washed once with sterile PBS, 100 µl of 2,2’-azino-bis(3-ethylbenzothiazoline-6-
sulphonic acid) substrate were added to each well and incubation proceeded for 15 
minutes at 22°C. The absorbance of these solutions was measured at 490 nm (reference 
wavelength), and 405 nm with respect to a substrate solution blank containing no lysate. 
In separate, untreated wells, cells were trypsinized using 0.25% trypsin-EDTA and 
trypan-blue excluding cells were counted on a haemocytometer. The absorbance values 
obtained in each sample were then normalized for cell number. 
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2.8 Preparation of cell lysates for protein analysis 
To prepare keratinocyte lysates, cells were gently scraped from culture dishes using a 
Teflon cell scraper, and collected in the culture medium. This cell suspension was 
transferred to a 15-ml conical tube and centrifuged at 200 x g for 10 minutes at 22°C. 
After centrifugation, the supernatants were removed by aspiration, and the cell pellets 
were either processed immediately to prepare lysates, or frozen in liquid nitrogen for 
storage at -80°C until used.  
For immunoblotting experiments, keratinocyte pellets were resuspended in approximately 
four pellet volumes of a modified radioimmunoprecipitation assay (RIPA) buffer (50 mM 
Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 1 mM PMSF, 
10 mM Na3VO4, 1 µg/ml NaF, 1 µg/ml aprotinin, 1 µg/ml pepstatin, 1 µg/ml leupeptin) 
and incubated on ice for 30 minutes. Lysates were then centrifuged at 18,000 x g for 10 
minutes at 4°C, and the supernatants were transferred to a new microcentrifuge tube. The 
protein concentration in each lysate sample was determined using Bradford assays. 
In experiments involving analysis of phosphorylated proteins, cell pellets were 
resuspended as above, but the buffer used was PhosphoSafe extraction reagent 
supplemented with 1 mM PMSF. Unless otherwise indicated, 50 µg of protein per sample 
were used for immunoblot analyses.  
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2.9 Denaturing polyacrylamide gel electrophoresis and 
immunoblotting 
Cell lysates were heated to 99°C for 7 minutes, and then resolved by denaturing 
polyacrylamide gel electrophoresis (SDS-PAGE), (5% stacking and 10% or 15% 
resolving polyacrylamide). Proteins in the gel were transferred to Immobilon-P 
Polyvinylidene fluoride (PVDF) membranes (Millipore, Catalogue No. IPVH00010) 
using a semi-dry transfer apparatus. After transfer, the membranes were blocked in 5% 
skim milk diluted in Tris-buffered saline supplemented with 0.05% Tween-20 (TBST, 
100 mM Tris-HCl pH 7.5, 0.9% NaCl) with gentle rocking for 1 hour at 22°C. The 
membranes were probed with primary antibodies indicated in individual experiments, 
diluted in TBST. For incubations with primary antibodies, the membranes were placed in 
50-ml FalconTM tubes containing 5 ml of the appropriate antibody dilutions, and the tubes 
were secured to a rotating platform. The tubes were rotated at 8 rpm for 2 hours at 22°C, 
or overnight at 4°C. Following incubation with primary antibodies, the membranes were 
washed three times with TBST for 5 minutes per wash. They were then incubated with 
the appropriate HRP-conjugated secondary antibody (1:5000 v/v in 5% skim milk diluted 
in TBST) for 1 hour at 22°C. Membranes were washed thoroughly three times with 
TBST for 15 minutes per wash. Amersham ECL Prime Western Blotting Detection 
Reagent was added to the membranes and proteins were visualized using UltraCruz 
autoradiography film (Santa Cruz, Catalogue No. SC-201697). All results presented are a 
representative of 3-5 biological replicates. 
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When necessary, the PVDF membranes were stripped using a guanidine hydrochloride-
based stripping solution (20 mM Tris-HCl pH 7.5, 6 M guanidine hydrochloride, 0.02% 
NP-40, 0.8% 2-mercaptoethanol) (Yeung and Stanley, 2009). To this end, membranes 
were incubated with gentle rocking in stripping solution for 10 minutes at 22°C. The 
solution was replaced with fresh stripping solution and incubation proceeded for 10 
additional minutes. The membranes were then washed thrice with 15 ml of TBST (10 
minutes per wash), before probing with another primary antibody.  
To quantify protein levels in immunoblots, densitometry analysis was conducted using 
ImageJ (Fiji) (Schindelin et al., 2012). Rectangles of equal size were drawn around the 
bands of interest on scanned images of immunoblots. A profile plot of each band as well 
as the background area was obtained, which represented the pixel density in a given 
rectangle. Background values were subtracted, and the densitometric value of each lane 
was obtained.  
 
2.10 Preparation of glass coverslips 
Glass coverslips were incubated for 4 to 16 hours in 1 M HCl at 50-60°C. Once cooled, 
the glass coverslips were rinsed thoroughly with 18 MΩ water, washed with ethanol, and 
allowed to dry. The coverslips were then coated with poly-L-lysine (PLL) (1 mg/ml) by 
rocking for 1 hour at 22°C. PLL-coated coverslips were washed thoroughly with 18 MΩ 
water and allowed to dry. The glass coverslips were then sterilized by immersion 70% 
ethanol for 10 minutes at 22°C, and washed three times with sterile PBS. Sterile 
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coverslips were further coated overnight at 37°C with a solution containing 50 µg/ml rat 
tail collagen type I dissolved in 0.02 N acetic acid, followed by three washes with sterile 
PBS.  
 
2.11 Confocal and immunofluorescence microscopy 
For experiments involving immunofluorescence or confocal microscopy, primary 
keratinocytes isolated from ILK-expressing and ILK-deficient epidermis were seeded on 
glass coverslips at a density of 3x105 cells/2 cm2 and 8x105 cells/2 cm2, respectively. 
When cells reached 80% confluence, they were fixed with freshly diluted 4% PFA for 40 
minutes on ice, and washed thoroughly with PBS three times. Cells were permeabilized 
with 0.1% Triton X-100 solution in PBS for 20 minutes at 22°C and then washed with 
PBS three times. The samples were blocked in 3% skim milk containing 5% goat serum 
for 1 hour at 22°C with gentle rocking. After three washes with PBS, primary antibody 
solution was added and incubation proceeded at 22°C for 2 hours, or 4°C overnight with 
gentle rocking, as indicated in individual experiments. Primary antibodies were diluted in 
PBS containing 5% goat serum. Cells were then washed three times with PBS at 22°C 
with gentle rocking (5 minutes per wash) and incubated with the appropriate 
AlexaFluorTM-conjugated secondary antibody (1:500 v/v in PBS with 3% skim milk and 
1% goat serum) for 1 hour at 22°C, protected from light. Cells were washed three times 
with PBS (10 minutes per wash) and then incubated with Hoechst 33342 to visualize 
nuclear DNA (1:10,000 v/v, 1 µg/ml, final) for 15 minutes at 22°C with gentle rocking. 
Following three 5-minute washes with PBS, the glass coverslips were mounted onto 
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microscope slides, using Immu-mount mounting medium. Samples were allowed to dry 
overnight at 22°C in the dark before analysis. Immunofluorescence micrographs were 
obtained with a Leica DMIRBE fluorescence microscope (Leica Microsystems, Wetzlar, 
Germany) equipped with an Orca-ER digital camera (Hamamatsu Photonics, 
Hamamatsu, Japan), using Volocity 4.3.2 software. Confocal images were obtained using 
ZEN 2009 software (Zeiss, Germany) and a Zeiss LSM5 DUO scanner laser confocal 
microscope (Jena, Germany), equipped with a 63X/1.4 NA oil immersion lens. 
For analysis of Bax localization to the mitochondrial marker Tom20, colocalization 
analysis was conducted on a pixel-by-pixel basis using the ZEN2009 software. For each 
biological replicate, the regions of interest (ROI) of 27 to 33 cells were selected. The 
pixel distributions of each ROI were displayed and colocalization values were calculated. 
The green (Bax) and red (Tom20) colocalization coefficients were calculated by 
summing the number of colocalized pixels of each ROI and dividing by the total sum of 
either green or red pixels, respectively. Colocalization values were adjusted for pixel 
intensity of the individual channels, giving rise to the weighted colocalization 
coefficients.  
 
2.12 Quantification of reactive oxygen species (ROS) 
K14Cre+/-;Ilkf/+ and K14Cre+/-;Ilkf/f keratinocytes were plated at a density of 1x105 
cells/0.32 cm2 on a 96-well plate coated with a 50 µg/ml collagen solution. Two days 
after plating, the cells were washed once with sterile PBS and incubated with 100 µl of 
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10 µM 2’,7’-dichlorofluorescein diacetate (DCFDA) dye dissolved in sterile PBS for 45 
minutes at 37°C in the dark. The DCFDA solution was removed by aspiration, and cells 
were washed once with sterile PBS. Solutions containing H2O2 (50, 100, 200, 400, and 
500 µM) were prepared using sterile PBS from a 50 mM H2O2 stock (as described in 
Section 2.4). In duplicate, 100 µl of each H2O2 dilution was then added to each well. 
Fluorescence was read on a microplate reader at timed intervals after H2O2 addition (5, 
10, 15, 20, 35, 50 minutes), with an excitation wavelength of 490 nm and an emission 
wavelength of 535 nm using Softmax Pro Version 5 software. In separate, untreated 
wells, cells were trypsinized using 50 µl of 0.25% trypsin-EDTA and trypan-blue 
excluding cells were counted on a haemocytometer. Fluorescence values were 
normalized for cell number.   
In experiments using N-acetylcysteine, cells were washed once with sterile PBS and 
incubated with 100 µl of 2 or 5 mM NAC diluted in culture medium for 40 minutes at 
37°C prior to the addition of DCFDA. The cells were then processed as described above.
2.13 Statistical analysis 
Statistical analyses were conducted using one-way analysis of variance (ANOVA) with 
Bonferroni post-hoc test using GraphPad Prism version 5. Significance was set to P≤0.05. 
All experiments were conducted 3-5 times.   
44 
Chapter 3 – Results 
All experiments were completed by Michelle Im except for the following: (i) 
measurement of apoptosis was performed by T.S. Irvine. 
3.1 Proliferation of ILK-deficient keratinocytes 
Integrins and their downstream effectors play a key role in cell-ECM attachment and 
signal transduction (reviewed in Hinz, 2010). Specifically, in epidermal keratinocytes, 
integrins are essential for keratinocyte spreading, adhesion, and proliferation (Choma et 
al., 2006; Raghavan et al., 2000). ILK is a β1 integrin effector, but its contribution to 
keratinocyte proliferation and viability remain unknown. To begin to address this issue, I 
first determined the role of ILK in keratinocyte proliferation by comparing changes in 
cell numbers as a function of time in ILK-expressing and ILK-deficient cultures. 
Keratinocytes isolated from ILK-expressing K14Cre;Ilkf/+ and ILK-deficient K14Cre;Ilkf/f 
mice were seeded on 24-well plates at a density of 200,000 cells per well. Twenty-four 
hours after plating, the number of trypan blue-excluding, viable cells averaged 114,000 
and 95,000 cells per well in the ILK-expressing and ILK-deficient cultures, respectively 
(Figure 3.1). This indicates a plating efficiency of 50-55% for cells of both genotypes. 
The number of K14Cre;Ilkf/+ keratinocytes remained constant until 72 hours after plating, 
and increased thereafter, so that by 120 hours in culture, the number of cells averaged 
200,000 per well (Figure 3.1). In contrast, the number of ILK-deficient K14Cre;Ilkf/f cells 
progressively decreased, reaching approximately 30,000 cells per well 120 hours after 
plating.  This  decrease  in  cell  number  suggests  that  ILK-deficient  keratinocytes  may  
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Figure 3.1. Proliferation of ILK-deficient keratinocytes.  
Keratinocytes isolated from Ilkf/f, K14Cre;Ilkf/+, and K14Cre;Ilkf/f mice were plated at 
2x105 cells/2 cm2. At the indicated times after plating, the number of cells was 
determined. The results are expressed as the mean ±SD (n=3). * indicate p<0.05, relative 
to cell numbers at the corresponding times in Ilkf/f keratinocytes (ANOVA). 	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exhibit survival and proliferation defects. Similar experiments were conducted with Ilkf/f 
cells, which contain two functional Ilk alleles. The changes in cell number over time in 
these cells were indistinguishable from those observed in K14Cre;Ilkf/+ cells (Figure 3.1), 
suggesting that gene dosage effects on proliferation are negligible, if any. 
In a complementary approach, I measured the fraction of cells synthesizing DNA in these 
cultures. To this end, I determined the fraction of cells capable of incorporating 
bromodeoxyuridine (BrdU) into their DNA. BrdU is a synthetic thymidine analog used to 
quantify proliferating cells, as it is incorporated into DNA during the S phase of the cell 
cycle (Pierce et al., 1994). To quantify the percentage of keratinocytes in S-phase, 
K14Cre;Ilkf/+ and K14Cre;Ilkf/f cells were incubated with BrdU for 2 hours, and the 
fraction of BrdU-positive was then determined by immunofluorescence miscosopy 
(Figure 3.2A).  Twenty-four hours after plating, the percentage of BrdU-positive 
keratinocytes was 8% and 5%, in cells isolated from ILK-expressing and ILK-deficient 
epidermis, respectively (Figure 3.2B). By 48 hours, the proportion of BrdU-positive 
keratinocytes significantly increased to approximately 30% in both cell types. However, 
72 hours after plating, there was a significant decrease in BrdU-positive ILK-deficient 
cells and after 96 hours in culture, the percentage of BrdU-positive keratinocytes had 
reached approximately 40% in ILK-expressing cells, whereas it was only 20% in ILK-
deficient cells. Together, these findings indicate that ILK-deficient keratinocytes have a 
reduced proliferative capacity compared to ILK-expressing cells.  
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Figure 3.2. Proportion of BrdU-positive cells in ILK-deficient epidermis.  
Keratinocytes isolated from K14Cre;Ilkf/+ and K14Cre;Ilkf/f mice were plated at 2x105 
cells/2 cm2. Epidermal keratinocytes were incubated with 10 µM bromodeoxyuridine 
(BrdU) for 2 hours at 37°C. A) The presence of BrdU was assessed by 
immunofluorescence microscopy. At the indicated times after plating, the number of 
BrdU-positive cells was determined. Bar, 32 µm. B) The results are expressed as the 
mean ±SE of 100 cells per genotype (n=3). * indicate p<0.05, relative to percentages of 
BrdU-positive cells at corresponding times in ILK-expressing K14Cre;Ilkf/+ keratinocytes 
(ANOVA). 	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3.2 Apoptosis in cultured ILK-deficient keratinocytes 
The reduction in the number of ILK-deficient cells observed in the experiments of Figure 
3.1 may arise from decreases in cell viability, in addition to an impaired ability to 
traverse the cell cycle. Cell death can occur through various mechanisms, including 
apoptosis. Apoptosis is a highly regulated programme of cell death, characterized at its 
latest stages by the activation of endogenous nucleases, which cleave DNA at accessible 
internucleosomal sites (Yoshida et al., 2006). Thus, I next examined if there are 
differences in the levels of mono- and oligonucleosomes in cytosolic fractions of cell 
lysates, indicative of apoptotic cells in these cultures. Under optimal culture conditions 
(i.e. in the presence of serum and growth factors necessary to maintain keratinocytes), 
ILK-deficient keratinocytes exhibited a higher content of mono- and oligonucleosomes 
than ILK-expressing cells (Figure 3.3), indicating a larger proportion of apoptotic cells in 
these cultures. Culture of mammalian cells requires growth and survival factors. In 
keratinocyte cultures, these factors are provided by the fetal bovine serum and HICET3 
supplements (hydrocortisone, insulin, cholera toxin, EGF, and triiodothyronine) present 
in the growth medium. To investigate if ILK-deficient keratinocytes are more sensitive 
than normal cells to growth factor deprivation, I measured apoptosis in cells cultured in 
the absence of HICET3, FBS, or both. In medium with FBS but lacking HICET3, there 
were no significant differences in the proportion of apoptotic cells between ILK-
expressing and ILK-deficient cultures (Figure 3.3). In contrast, ILK-deficient 
keratinocytes cultured with HICET3, but without FBS, demonstrated significantly greater 
apoptosis  than  ILK-expressing  cells  (Figure  3.3).   Finally,  both  cell  types  displayed  
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Figure 3.3. Effect of Ilk gene inactivation on apoptosis.  
Keratinocytes isolated from K14Cre;Ilkf/+ and K14Cre;Ilkf/f mice were plated at 1x105 
cells/ 2 cm2. Cells were cultured in the indicated treatment conditions for 16 hours. Cell 
death was photometrically quantified as a function of mono- and oligonucleosome 
concentration in the cytoplasmic fraction of cell lysates in indicated conditioned medium. 
The results are expressed as the mean +SEM (n=6) and * indicate p<0.05, relative to 
absorbance in ILK-expressing K14Cre;Ilkf/+ keratinocytes (ANOVA). Absorbance was 
measured at 490 nm as the reference wavelength, and 405 nm with respect to a substrate 
solution blank.   
 
0.0
0.5
1.0
1.5
2.0
2.5
A
40
5-A
49
0 *
*
+
+
+
+-
- -
-HICET3
FBS
K14Cre;Ilkf/+ (ILK-expressing)
K14Cre;Ilkf/f (ILK-deficient)
52 
53 
similar levels of apoptosis in the absence of all growth factors (when medium was only 
supplemented with BSA) (Figure 3.3). These findings indicate that, in addition to a 
diminished ability to proliferate, ILK-deficient cells have increased sensitivity to growth 
factor deprivation and enhanced susceptibility to apoptosis, even in “optimal” culture 
conditions. 
3.2.1 Role of the Akt pathway in increased apoptosis in ILK-deficient 
keratinocytes 
To begin to elucidate the signalling pathway involved in the ILK-mediated survival of 
keratinocytes, I investigated changes in levels of proteins that specifically participate in 
cell survival. Protein kinase B (Akt), having an established role in promoting survival in a 
number of cell types (Song, et al., 2005; Zhao et al., 2006), has often been linked to ILK 
and even suggested to be one of its direct, downstream substrates (McDonald et al., 
2008).  Cells from K14Cre;Ilkf/+ and K14Cre;Ilkf/f mice were cultured under optimal 
growth conditions, or in medium containing only FBS, HICET3, or BSA, for 16 hours, 
and levels of phosphorylated, active Akt (phospho-Akt) were determined. Under all 
treatment conditions, there were no significant differences in phosphorylated levels of 
Akt between ILK-expressing and ILK-deficient keratinocytes (Figure 3.4). Thus, my 
findings suggest that Ilk inactivation does not lead to altered activation of Akt and the 
increased apoptosis observed in ILK-deficient keratinocytes seems to be independent of 
the Akt pathway. 
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Figure 3.4. Effect of Ilk gene inactivation on Akt phosphorylation.  
Keratinocytes isolated from K14Cre;Ilkf/+ and K14Cre;Ilkf/f epidermis were cultured in 
the indicated treatment conditions for 16 hours. Protein lysates were prepared and 
resolved by denaturing gel electrophoresis, followed by immunoblot analysis using 
indicated antibodies (top panel).  Densitometry analyses are expressed as the mean +SEM 
(n=3) relative to corresponding expression levels in ILK-expressing K14Cre;Ilkf/+ 
keratinocytes in Complete medium (set to 1). 
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3.3 Role of the mitochondrial localization of Bax in apoptosis 
of ILK-deficient keratinocytes 
Bax is a pro-apoptotic protein that localizes to the cytoplasm in viable cells, but 
translocates to the outer membrane of the mitochondria to mediate the release of 
additional pro-apoptotic proteins into the cytoplasm, eventually resulting in cell death 
(Stankiewicz et al., 2005). Mitochondrial translocation of Bax is involved in the 
activation of the caspase-dependent intrinsic apoptotic pathway (Laethem et al., 2004). 
To investigate if changes in Bax distribution accompany the increased apoptosis observed 
in ILK-deficient keratinocytes, I examined its subcellular localization by confocal 
microscopy. K14Cre;Ilkf/+, and K14Cre;Ilkf/f cells were plated, fixed, and stained with 
Bax and Tom20 antibodies. Colocalization analysis on 27 to 33 individual cells per 
genotype was conducted based on pixel distribution. Colocalization coefficients were 
calculated for each cell and adjusted for pixel intensity of the individually, coloured 
channels. Whereas Bax was predominantly localized to the cytoplasm in ILK-expressing 
cells, a higher proportion of Bax was found to co-localize to the mitochondria in ILK-
deficient keratinocytes (Figure 3.5A). In ILK-expressing keratinocytes, approximately 
20% of the total cellular Bax was localized in the mitochondria. However, almost 65% of 
the total Bax were found to localize to the mitochondria in ILK-deficient cells (Figure 
3.5B). Similarly, whereas ILK-expressing cells exhibited roughly 15% of Bax-positive 
mitochondria, almost 85% of the mitochondria in ILK-deficient keratinocytes co-
localized with Bax (Figure 3.5B). My observations are consistent with the notion that this  
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Figure 3.5. Bax mitochondrial localization in ILK-deficient cells.  
Keratinocytes isolated from K14Cre;Ilkf/+ and K14Cre;Ilkf/f mice were plated 3x105
cells/2 cm2 and 8x105 cells/2 cm2, respectively. Epidermal keratinocytes were then fixed 
with 4% paraformaldehyde and stained for Bax and Tom20. A) Stained cells were 
visualized by confocal microscopy. Bar, 15 µm. B) Weighted colocalization coefficients 
were calculated using ZEN2009 software. The results are expressed as the mean ±SE of 
27 to 33 cells per genotype (n=3). * indicate p<0.05 (student’s t-test). 
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increased Bax mitochondrial translocation may be involved in activating the downstream 
caspase-mediated apoptosis pathway in the absence of ILK. Thus, increased apoptosis in 
ILK-deficient keratinocytes is associated with Bax localization to the mitochondria, 
which may be involved in stimulating downstream caspases.  
3.3.1 Activation of the MAPK pathway in ILK-deficient keratinocytes 
Bax translocation to the mitochondria is triggered by both intracellular and extracellular 
stress stimuli. The activation of the mitogen-activated protein kinase (MAPK) pathway is 
highly involved in cellular stress response and mediates the mitochondrial localization of 
Bax, ultimately leading to stress-induced apoptosis (Katiyar et al., 2001). Specifically, I 
sought to determine the effect of Ilk inactivation on the activation by phosphorylation of 
c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK). ILK-
deficient keratinocytes displayed higher levels of phospho-JNK (Figure 3.6) and 
phospho-ERK (Figure 3.7) compared to those in ILK-expressing cells, irrespective of 
whether the cells were cultured under optimal growth conditions or in growth factor-
deficient medium. Thus, my findings suggest a possible involvement of the MAPK 
pathway in mediating apoptotic levels of keratinocytes, specifically through its 
modulatory role in the activation of the pro-apoptotic function of Bax. 
3.3.2 Activation of Bax-caspase pathway in apoptosis in ILK-deficient 
keratinocytes 
The above observations prompted me to investigate if the increased apoptosis in ILK-
deficient  cells  was  accompanied  by the formation of active caspases. During apoptosis,  
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Figure 3.6. ILK-deficiency is associated with JNK phosphorylation.  
Keratinocytes isolated from K14Cre;Ilkf/+ and K14Cre;Ilkf/f epidermis were cultured in 
the indicated treatment conditions for 16 hours. Protein lysates were prepared and 
resolved by denaturing gel electrophoresis, followed by immunoblot analysis using 
indicated antibodies (top panel). Levels of phospho-JNK are expressed as the mean 
+SEM (n=3) relative levels in ILK-expressing K14Cre;Ilkf/+ keratinocytes in Complete 
medium (set to 1). * indicate p<0.05, relative to expression levels in ILK-expressing 
K14Cre;Ilkf/+ keratinocytes in corresponding conditioned medium (ANOVA, bottom 
panel).  
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Figure 3.7 ILK-deficiency is associated with ERK phosphorylation.  
Keratinocytes isolated from K14Cre;Ilkf/+ and K14Cre;Ilkf/f epidermis were cultured in 
the indicated treatment conditions for 16 hours. Protein lysates were prepared and 
resolved by denaturing gel electrophoresis, followed by immunoblot analysis using 
indicated antibodies (top panel). Levels of phospho-ERK are expressed as the mean 
+SEM (n=3) relative levels in ILK-expressing K14Cre;Ilkf/+ keratinocytes in Complete 
medium (set to 1). * indicate p<0.05, relative to expression levels in ILK-expressing 
K14Cre;Ilkf/+ keratinocytes in corresponding conditioned medium (ANOVA, bottom 
panel).  
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cytochrome c released from the mitochondria into the cytosol binds to the apoptotic 
protease-activating factor 1 to form apoptosomes (Du et al., 2000). This oligomerized 
complex then induces the autoactivation of procaspase-9, which in turn cleaves and 
activates downstream caspases, including caspase-3 (Du et al., 2000). Therefore, I 
examined the levels of active, cleaved caspase-3 in keratinocyte lysates cultured under 
normal or growth-factor deprivation conditions, as described in Section 3.2. Under 
optimal growth conditions, cleaved caspase-3 levels were significantly higher in ILK-
deficient cells, relative to ILK-expressing keratinocytes (Figure 3.8). In medium 
containing only FBS, there were no significant differences in cleaved caspase-3 levels 
between cells isolated from ILK-expressing and ILK-deficient epidermis. Similarly, 
cleaved caspase-3 levels in ILK-deficient keratinocytes cultured in medium lacking FBS 
but containing HICET3, were indistinguishable from those displayed by ILK-expressing 
cells (Figure 3.8). However, ILK-deficient keratinocytes cultured in serum- and growth 
factor-free medium only supplemented with BSA displayed significantly increased levels 
of cleaved caspase-3 compared to ILK-expressing cells, even though cleaved caspase-3 
abundance in BSA-containing medium was substantially higher in both ILK-expressing 
and ILK-deficient cells (Figure 3.8).  
To complement these experiments, I also measured levels of cleaved Poly-ADP Ribose 
Polymerase (PARP). PARP is normally involved in repairing DNA damage; however, 
during apoptosis, caspase-3 cleaves and inactivates PARP (Boulares et al., 1999). Thus, 
the presence of cleaved PARP is indicative of the activation of caspase-3. Under optimal 
growth conditions, ILK-deficient keratinocytes displayed significantly greater levels of 
cleaved  PARP  relative to  ILK-expressing  cells (Figure 3.9). Similarly  in  medium with  
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Figure 3.8. Effect of Ilk gene inactivation on cleavage of caspase-3.  
Keratinocytes isolated from K14Cre;Ilkf/+ and K14Cre;Ilkf/f epidermis were cultured in 
the indicated treatment conditions for 16 hours. Protein lysates were prepared and 
resolved by denaturing gel electrophoresis, followed by immunoblot analysis using 
indicated antibodies (top panel). Levels of cleaved Caspase-3 are expressed as the mean 
+SEM (n=3) relative levels in ILK-expressing K14Cre;Ilkf/+ keratinocytes in Complete 
medium (set to 1). * indicate p<0.05, relative to expression levels in ILK-expressing 
K14Cre;Ilkf/+ keratinocytes in corresponding conditioned medium (ANOVA, bottom 
panel).  
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Figure 3.9. ILK-deficiency is associated with PARP activation. 
Keratinocytes isolated from K14Cre;Ilkf/+ and K14Cre;Ilkf/f epidermis were cultured in 
the indicated treatment conditions for 16 hours. Protein lysates were prepared and 
resolved by denaturing gel electrophoresis, followed by immunoblot analysis using 
indicated antibodies (top panel). Levels of cleaved PARP are expressed as the mean 
+SEM (n=3) relative levels in ILK-expressing K14Cre;Ilkf/+ keratinocytes in Complete 
medium (set to 1). * indicate p<0.05, relative to expression levels in ILK-expressing 
K14Cre;Ilkf/+ keratinocytes in corresponding conditioned medium (ANOVA, bottom 
panel).  
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only FBS, cleaved PARP levels were significantly higher (approximately 5-fold) in ILK-
deficient cells, relative to ILK-expressing control keratinocytes. In cultures maintained in 
medium with HICET3 or BSA only, levels of cleaved PARP were indistinguishable 
between keratinocytes isolated from ILK-expressing and ILK-deficient epidermis, and 
cellular levels of cleaved PARP were highest in growth factor-deprived cultures (Figure 
3.9). These findings are consistent with the notion that the increases in apoptosis 
observed in ILK-deficient cells occur through pathways that involve caspase activation, 
both under normal conditions and under growth factor deprivation.  
3.4 Reactive oxygen species in ILK-deficient cells 
Caspase-dependent apoptosis can be triggered by a variety of stimuli, including elevated 
levels of reactive oxygen species (ROS) (Denning et al., 2002). Thus, I examined if the 
increased apoptosis observed in ILK-deficient keratinocytes was associated with altered 
cellular ROS. To quantify hydroxyl radicals, peroxyl radicals, and superoxide anions, 
cells were incubated with the fluorogenic dye, 2’,7’-dichlorofluorescein-diacetate 
(DCFDA). DCFDA passively diffuses through the plasma membrane into the cytoplasm, 
where it is deacetylated by endogenous esterases to yield a non-fluorescent, membrane-
impermeable conjugate (Wang and Joseph, 1999). The resulting compound is 
subsequently oxidized to a fluorescent species upon reaction with intracellular ROS 
(Wang and Joseph, 1999). For these studies, I incubated K14Cre;Ilkf/+ and K14Cre;Ilkf/f 
keratinocytes in medium with 10 µM DCFDA for 45 minutes at 37°C. The DCFDA-
loaded cells were then challenged with various concentrations of hydrogen peroxide (0, 
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50, 100, 200, 400, and 500 µM H2O2), an established source of free radicals. ROS levels 
were then determined as a function of time. In the absence of H2O2, keratinocytes lacking 
Ilk gene expression exhibited significantly higher ROS levels compared to ILK-
expressing control cells at all incubation times (Figure 3.10; Figure 3.11A). Increase in 
ROS levels in ILK-deficient cells was further enhanced when cells were challenged with 
500 µM H2O2 (Figure 3.11B). ROS levels for both cell types increased gradually over the 
45-minute incubation period, both in the presence and absence of H2O2. These 
experiments indicate that ILK-deficient cells have an altered redox state, and suggest that 
increased ROS may be a potential source of stress triggering the activation of the 
apoptosis pathway in ILK-deficient keratinocytes. 
Keratinocytes with Ilk gene inactivation display increased levels of intracellular ROS 
compared to ILK-expressing keratinocytes (Figure 3.10), which may be caused by an 
increase in overall ROS production and/or a diminished ability to quench free radical 
species. Thus, I aimed at investigating the latter by treating cells with N-Acetyl-L-
cysteine (NAC), a synthetic derivative of intracellular cysteine that serves as a precursor 
in the biosynthesis of glutathione, an antioxidant (Aruoma et al., 1989). K14Cre;Ilkf/+ and 
K14Cre;Ilkf/ keratinocytes were cultured on a 96-well plate and supplemented with 2 or 5 
mM NAC in normal culture medium for 40 minutes at 37°C. Cells were then incubated 
with 10 µM DCFDA for 45 minutes at 37°C, and subsequently challenged with 500 µM 
H2O2. ROS-associated fluorescence was quantified on a microplate reader immediately 
(Figure 3.12A) and 45 minutes after (Figure 3.12B) the addition of H2O2, and normalized 
for cell number. In the presence of 500 µM H2O2, ROS levels in both ILK-expressing and 
ILK-deficient  cells  increased  significantly.   However,  when  ILK-deficient  cells  were  
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Figure 3.10. Effect of Ilk gene inactivation on cellular ROS levels.  
Keratinocytes isolated from K14Cre;Ilkf/+ and K14Cre;Ilkf/f mice were plated at 1x105 
cells/0.32 cm2. Epidermal keratinocytes were incubated with 10 µM 2’,7’-
dichlorofluorescin diacetate (DCFDA) dye for 45 minutes at 37°C in the dark. 
Fluorescence was read in arbitrary units on a plate reader, with an excitation wavelength 
of 490 nm and an emission wavelength of 535 nm and normalized for cell number. The 
results are expressed as the mean ±SE (n=3). * indicate p<0.05, relative to fluorescence 
of corresponding ILK-expressing K14Cre;Ilkf/+ keratinocytes (t-test).  
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Figure 3.11. ROS in ILK-deficient keratinocytes.  
Keratinocytes isolated from K14Cre;Ilkf/+ and K14Cre;Ilkf/f mice were plated at 1x105 
cells/0.32 cm2. Epidermal keratinocytes were incubated with 10 µM 2’,7’-
dichlorofluorescin diacetate (DCFDA) dye for 45 minutes at 37°C in the dark. 
Keratinocytes were treated with increasing A) incubation time and B) concentration of 
hydrogen peroxide (H2O2). Fluorescence was read on a plate reader, with an excitation 
wavelength of 490 nm and an emission wavelength of 535 nm and normalized for cell 
number. The results are expressed as the mean ±SE (n=3), relative to corresponding 
fluorescence in ILK-expressing K14Cre;Ilkf/+ epidermis with no H2O2 (set to 1). * and # 
indicate p<0.05, relative to fluorescence of corresponding H2O2 treated and untreated 
ILK-expressing K14Cre;Ilkf/+ keratinocytes, respectively (ANOVA).  
 
K14Cre;Ilkf/+
K14Cre;Ilkf/+ 
(500µM H2O2)
K14Cre;Ilkf/f
K14Cre;Ilkf/f 
(500µM H2O2)
R
el
at
iv
e 
Fl
uo
re
sc
en
ce
Incubation time (min)
0.0 
1.0 
2.0 
3.0 
4.0 
5.0 
6.0 
7.0 
5 10 15 20 35 50 
#
*
0.0 
1.0 
2.0 
3.0 
4.0 
5.0 
6.0 
7.0 
0 50 100 200 400 500 
R
el
at
iv
e 
Fl
uo
re
sc
en
ce
K14Cre;Ilkf/+ 
(5 min)}}
H2O2 concentration (μM)
K14Cre;Ilkf/f 
(5 min)
K14Cre;Ilkf/+ 
(45 min)
K14Cre;Ilkf/f 
(45 min)
* *
*
*
*
# #
# #
#
A)
B)
*
*
*
* *
*
#
#
#
#
74 
75 
 
 
  
 
 
 
 
 
Figure 3.12. Effect of NAC on ROS in ILK-deficient keratinocytes.  
Keratinocytes isolated from K14Cre;Ilkf/+ and K14Cre;Ilkf/f mice were plated at 1x105 
cells/0.32 cm2. Epidermal keratinocytes were incubated with 2 or 5 mM NAC for 40 
minutes at 37°C and replaced with 10 µM 2’,7’-dichlorofluorescin diacetate (DCFDA) 
dye for 45 minutes at 37°C in the dark. Fluorescence was read on a plate reader A) 
immediately and B) 45 minutes after addition of H2O2, with an excitation wavelength of 
490 nm and an emission wavelength of 535 nm and normalized for cell number.  
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incubated with 2 or 5 mM NAC, ROS abundance diminished to levels indistinguishable 
from those in ILK-expressing keratinocytes (Figure 3.12). Additionally, when NAC-
treated cells were challenged with H2O2, ROS levels were significantly reduced, 
compared to the amount ROS in vehicle-treated cells. However, even in the presence of 
NAC, ROS levels were higher in ILK-deficient cells, compared with ILK-expressing 
keratinocytes. Our findings suggest that apart from the possibility that cells lacking ILK 
may be generating excessive ROS, they may also have a reduced ability to quench and 
eliminate intracellular free radicals.  
 
3.5 DNA damage markers in ILK-deficient keratinocytes 
Increased cellular ROS levels may cause oxidative damage to DNA (Shi et al., 2004). To 
investigate if the loss of Ilk gene expression is accompanied by DNA damage, I measured 
levels of γH2A.X in keratinocytes cultured in normal growth medium, or subjected to 
growth factor deprivation. The levels of γH2A.X, a well-established marker for the 
activation of DNA damage response, such as DNA double-stranded breaks (DSB), were 
then analyzed. Under optimal culture conditions, I found significantly higher γH2A.X 
levels in ILK-deficient keratinocytes relative to ILK-expressing cells (Figure 3.13). 
Similarly, in keratinocytes cultured in medium containing only FBS, only HICET3, or 
only BSA, γH2A.X were significantly higher in ILK-deficient cells than ILK-expressing 
cells (Figure 3.13). Together, with the data from Section 3.4, these findings suggest that, 
in the absence of ILK, an increase in free radicals may contribute to elevated levels of 
γH2A.X as a consequent of DNA damage. 
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Figure 3.13. Effect of Ilk gene inactivation on γH2A.X levels.  
Keratinocytes isolated from K14Cre;Ilkf/+ and K14Cre;Ilkf/f epidermis were cultured in the 
indicated treatment conditions for 16 hours. Protein lysates were prepared and resolved by 
denaturing gel electrophoresis, followed by immunoblot analysis using indicated antibodies 
(top panel). Levels of γH2A.X are expressed as the mean +SEM (n=3) relative levels in ILK-
expressing K14Cre;Ilkf/+ keratinocytes in Complete medium (set to 1). * indicate p<0.05, 
relative to expression levels in ILK-expressing K14Cre;Ilkf/+ keratinocytes in corresponding 
conditioned medium (ANOVA, bottom panel).  
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Chapter 4 - Discussion 
4.1 Summary and general discussion 
When the Ilk gene is inactivated in mouse epidermal keratinocytes, the epidermal 
integrity becomes compromised and the viability of keratinocytes diminishes. Thus, the 
skin is unable to fulfill its defensive functions and becomes susceptible to oxidative stress 
and damage (Omari et al., 2008).  ILK plays a role in suppressing anoikis and apoptosis 
in various epithelial cell types (Benoit et al., 2007; Attwell et al., 2000); however, its role 
in maintaining keratinocyte viability remains poorly understood. My work now shows 
that ILK is necessary for keratinocyte viability, both under normal conditions and during 
growth factor deprivation. Further, I have begun to elucidate the mechanism whereby 
ILK limits stress-induced apoptosis in keratinocytes.  
4.1.1 Modulatory role of ILK on keratinocyte viability 
Basal keratinocytes, which are the predominant cell type in the basal layer of the 
epidermis, have a high proliferative capacity and are responsible for the self-renewal 
properties of the skin (Régnier et al., 1986). However, in the absence of ILK, 
keratinocytes lose their normal ability to divide and display a lower proportion of cells in 
S-phase, indicative of a reduced proliferative capacity. The diminished cell viability 
consequent to Ilk gene inactivation is associated with elevated levels of cell death through 
apoptosis, specifically involving the caspase pathway. My observations have shown that 
under optimal growth culture conditions, ILK-deficient keratinocytes display 
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significantly higher levels of cleaved caspase-3 and cleaved PARP compared to ILK-
expressing control cells, both indicative of the activation of the pro-apoptosis enzymatic 
caspase cascade. Notably, despite being the direct downstream substrate of caspase-3, 
cleaved PARP levels in ILK-expressing and ILK-deficient cells varied in expression 
pattern from cleaved caspase-3 levels under different culture conditions (and vice versa). 
Cleaved PARP was increased significantly in ILK-deficient keratinocytes in conditions of 
HICET3 growth supplement deprivation, whereas cleaved caspase-3 levels were elevated 
in ILK-deficient keratinocytes in the BSA serum-starved treatment. Such discrepancies 
observed in the different growth deprivation treatments could likely be attributed to either 
a potential role of ILK in promoting growth factor-mediated cell survival or parallel 
pathways facilitating the cleavage of either caspase-3 or PARP under specific culture 
conditions. Clearly, this hypothesis needs to be further investigated. 
The increased activation of the caspase pathway appears to also involve an increase in 
Bax localization to the mitochondria, a phenomenon necessary for the formation of the 
mitochondrial apoptosis-induced channel (MAC). MAC is a complex upstream of the 
intrinsic caspase pathway, which mediates the release of cytochrome c and ultimately, the 
activation of caspase-mediated apoptosis (Dejean et al., 2005). Although the role of ILK 
in the intrinsic apoptosis pathway has never been investigated in keratinocytes, previous 
findings conducted on SCP2 mouse mammary epithelial cells have shown that ILK 
overexpression interferes with the activation of caspase-3 and caspase-8, suppressing 
anoikis (Attwell et al., 2000). As caspase-8 is another key activator of caspase-3 via the 
extrinsic apoptotic pathway, these findings are consistent with the notion that ILK may 
play a role in modulating the intrinsic activation of apoptosis as well. However, in 
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addition to an increase in apoptosis, the diminished capacity of ILK-deficient 
keratinocytes to effectively proliferate could also be associated with increased 
senescence. Thus, it would be interesting to investigate differences in senescence 
between ILK-expressing and ILK-deficient keratinocytes. 
It is interesting to note that in epidermal keratinocytes, loss of ILK expression did not 
affect levels of active, pro-survival phosphorylated Akt. Under all culture treatment 
conditions used in my experiments, the levels of the activated form of Akt in ILK-
deficient keratinocytes remained indistinguishable from those observed in ILK-
expressing cells, indicating that the increased apoptosis in ILK-deficient keratinocytes is 
likely independent of Akt. Similarly, Akt is not altered in ILK-deficient fibroblasts and 
chondrocytes (Sakai et al., 2003; Grashoff et al., 2003; Boudeau et al., 2006). It would be 
interesting to investigate if ILK-deficiency has an effect on any of the downstream 
substrates of Akt, including Bcl-associated death promoter, or BAD. Measuring levels of 
phosphorylated BAD in the presence and absence of ILK could yield information 
regarding whether a different pathway may be activated in parallel to the intrinsic 
caspase-mediated apoptosis pathway. However, my experiments thus far suggest that ILK 
promotes cell survival in a manner independent of Akt in primary keratinocytes.  
4.1.2 Modulatory role of ILK on ROS-induced apoptosis 
One possible explanation for the significant increase in apoptosis observed in ILK-
deficient cells is elevated levels of cellular stress (Paz et al., 2007), and one of the most 
common sources of intracellular stress is reactive oxygen species (ROS) (Kovacs et al., 
2009). My findings show significantly increased ROS levels in ILK-deficient 
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keratinocytes. These novel observations suggest excessive production of oxidative 
radicals. Elevated cellular ROS were also observed in ILK-deficient keratinocytes 
challenged with H2O2, a known producer of ROS. Thus, my experiments suggest a novel 
role for ILK in the cellular redox state of keratinocytes. Though the mechanism whereby 
ILK modulates oxidative stress has yet to be explored, the abnormal ROS levels in ILK-
deficient keratinocytes may contribute to elevated apoptosis observed in these cells. 
Interestingly, over-production and accumulation of ROS within the endoplasmic 
reticulum (ER) have been shown to perturb ER function (Chaudhari et al., 2014). Such 
ER stress leads to the misfolding of proteins, and in cases of excessive stimulation by 
ROS, even apoptosis (Puthalakath et al., 2007). Thus, based on its role in modulating 
ROS levels in keratinocytes, ILK may also be involved in mediating ROS-induced 
apoptosis through the ER, as well as the mitochondria.  
Such marked differences in ROS levels in ILK-deficient keratinocytes may arise from 
increased production and/or an impaired ability to quench free radicals. Notably, ROS 
abundance was reduced to levels indistinguishable from those in ILK-expressing control 
cells in the presence of the reducing agent NAC. As a synthetic precursor of glutathione, 
a known endogenous antioxidant produced in cells, exogenous NAC indirectly acts as a 
ROS scavenger (Sun, 2010). My observations suggest that keratinocytes with Ilk gene 
inactivation may produce insufficient amounts of reducing compounds, thus resulting in 
elevated free radical species. More experiments will need to be conducted to support this 
hypothesis. 
Elevated levels of ROS can contribute to DNA damage, such as strand breaks (Shi et al., 
2004). Intracellular ROS induce damaged lesions to DNA, specifically through the 
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targeted conversion of guanine bases to reactive, oxidized 8-hydroxyguanine (Wiseman 
and Halliwell, 1996). Such base or sugar damage can ultimately lead to intra- and/or 
inter-strand breaks in DNA, triggering apoptosis (Flores et al., 2002). My experiments 
have shown that, in addition to abnormal levels of ROS, ILK-deficient keratinocytes 
display higher levels of γH2A.X, a marker for the activation of DNA damage responses, 
which is activated to repair DNA double-strand breaks. ILK-deficient keratinocytes may 
also have defects in their ability to effectively repair DNA, even under normal levels of 
oxidative stress. Whether increased DNA damage is associated with increased apoptosis 
observed in ILK-deficient keratinocytes has yet to be determined. When DNA is 
damaged, the cell can either attempt to repair it or initiate programmed cell death 
(Bouchard et al., 2003). If DNA damage is not excessive, Poly ADP ribose polymerase 
(PARP) is activated, binding to DNA strand breaks to facilitate the recruitment of 
proteins involved in DNA repair (Herceg and Wang, 2000). However, if DNA damage is 
too extensive, excessive PARP stimulation leads to NAD+ depletion through the 
overproduction of signalling PAR chains (Bouchard et al., 2003). Without NAD+, ATP 
cannot be synthesized and apoptosis is subsequently induced, as the cell exhausts all its 
energy sources (Bouchard et al., 2003). According to the PARP suicide hypothesis, this 
pathway then triggers the cleavage and inactivation of PARP by upstream caspases 
(Bouchard et al., 2003). Together with the observed increase in γH2A.X levels, my 
findings suggest that the increased levels of inactive, cleaved PARP observed in ILK-
deficient keratinocytes may be associated with irreparable ROS-induced DNA damage. 
Together, my observations suggest that ILK may participate in the suppression of 
oxidative stress-induced DNA damage and subsequent activation of the caspase-
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dependent apoptotic pathway. Clearly, this hypothesis remains to be tested 
experimentally. 
As mentioned earlier, the mitochondrial localization of Bax indicates the activation of 
intrinsic apoptosis pathways, normally in response to various stimuli including elevated 
ROS (Simon et al., 2000). The activation of the Bax-mitochondrial pathway may result 
from the phosphorylation and activation of mitogen-activated protein kinases (MAPK) 
(Wong et al., 2010). Specifically, I observed an increase in the levels of active, 
phosphorylated c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase 
(ERK) in ILK-deficient keratinocytes compared to ILK-expressing cells. When cells are 
exposed to abnormal ROS levels or other stressors, JNK is phosphorylated and activated 
as part of the intrinsic apoptotic triggers. Once activated, apoptotic stimuli can then either 
stimulate Bax mitochondrial translocation and/or activate the caspase cascade (Tournier 
et al., 2000). Previous experiments conducted on embryonic fibroblasts and 
erythroleukemia cells support my findings of increased levels of phosphorylated JNK in 
response to cells experiencing elevated levels of oxidative stress (Tournier et al., 2000; 
Nagata and Todokoro, 1999). However, there are a number of contrasting studies with 
respect to ROS-induced ERK phosphorylation that implicate a cell-type specific response 
(Xia et al., 1995). For example, similar to my observations in ILK-deficient 
keratinocytes, Xu et al. (2010) showed that triptolide, a potent epoxide, stimulates the 
generation of ROS in colorectal cancer cells. This increase in ROS levels lead to an 
increase in ERK activation and apoptosis (Tan and Chiu, 2013). However, in a study 
conducted by Xia et al. (1995), phospho-ERK levels decreased in response to apoptosis 
triggered by nerve growth factor withdrawal in cortical neurons, whereas phospho-JNK 
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levels increased. It appears that at least in cultured ILK-deficient keratinocytes, ERK 
phosphorylation is increased, potentially in response to elevated levels of ROS observed 
in these cells. Recent findings have also suggested that ERK may elicit either cell 
proliferation or apoptosis, depending on the degree of oxidative stress (Tan and Chiu, 
2013). 
Specifically, the JNK signalling pathway has been implicated in the activation of BH3-
only proteins, including Bim, Hrk, and Puma (Harris and Johnson, 2001). In cortical 
neurons, Bim and Hrk are stimulated by phosphorylated JNK upstream of the Bax 
mitochondrial complex to induce apoptosis (Harris and Johnson, 2001). Similarly, JNK 
has been shown to elicit its antiapoptotic function in hematopoietic pro-B cells through 
the phosphorylation and subsequent inactivation of proapoptotic Bcl-2 family protein, 
BAD (Yu et al., 2004). In human gingival fibroblasts, JNK activation by nitric oxide is 
associated with Bcl-2 family modulation and caspase activation via the mitochondrial 
pathway (Baek et al., 2014). Some studies have even suggested that stress-activated JNK 
and p38 kinases are directly involved in the phosphorylation and consequent 
mitochondrial translocation of Bax (Kim et al., 2006; Lei et al., 2002). 
These findings are consistent with a model I am proposing, based on my experimental 
observations (Figure 4.1). In this model ILK, which binds to β1 integrins, regulates ROS 
intracellular levels. This tight modulation of oxidative stress helps to suppress the 
hyperactivation of caspase-mediated apoptosis. However, in the absence of ILK, elevated 
ROS levels induce Bax to translocate to the mitochondria and stimulate the enzymatic 
caspase cascade, ultimately leading to apoptosis. 
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Figure 4.1. Proposed model of stress-induced apoptosis modulation by ILK.  
ILK-deficient keratinocytes display increased levels of apoptosis and intracellular ROS, 
suggesting that ILK may play a role in modulating stress-induced activation of the 
Caspase-3 pathway. 
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4.2 Significance 
Survival of keratinocytes is necessary for proper function of the skin (Chung et al., 2003). 
As a scaffold protein, ILK is involved in cell-cell and cell-ECM adhesion through its 
interaction with integrins (Teo et al., 2014). In the absence of ILK, epidermal integrity 
becomes compromised and the skin cannot maintain its protective function (Nakrieko et 
al., 2008; Eckes et al., 2014). My experiments demonstrate a novel role for ILK in 
modulating ROS levels in cultured keratinocytes. I have shown that ILK may play a role 
in maintaining keratinocyte survival, and that ILK loss is associated with ROS production 
and apoptosis. These findings could help elucidate the mechanisms by which the 
epidermis becomes susceptible to damage when the Ilk gene has been inactivated. For 
example, the kindlin family of adaptor proteins interacts with β-integrins to regulate 
integrin activation, similar to ILK (Böttcher et al., 2009). Kindler Syndrome is a rare, 
recessive disease of the skin that is caused by mutations in the kindlin-1 gene (Böttcher et 
al., 2009). Kindler Syndrome patients suffer severe blistering and abnormal pigmentation 
(Duperret and Ridkey, 2014), closely resembling the phenotypic defects observed in mice 
with epidermis-restricted inactivation of the Ilk gene (Nakrieko et al., 2008). Based on the 
functional similarities of ILK and kindlin in their integrin-related scaffolding functions, 
delineating the downstream factors involved in ILK-mediated keratinocyte survival could 
lead us to better understand the causes of various diseases, like Kindler Syndrome, that 
arise due to compromised integrity and function.  
My findings suggest a novel involvement of ILK in regulating apoptosis in keratinocytes. 
Apoptosis is a normal cellular process, necessary for proper maintenance and regulation 
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of cellular populations (Zuckerman et al., 2009). On one hand, insufficient levels of 
apoptosis are often correlated with tumourigenesis (Elmore, 2007; Nicholson, 2000). ILK 
has been proposed to be potential therapeutic target in various cancers (Hannigan et al., 
2005). ILK expression is elevated in prostate, gastric, and ovarian cancers, as well as in 
malignant melanomas (Hannigan et al., 2005). These findings may generate therapeutic 
solutions for maintaining epidermal health and even derive cancer therapies for 
oncogenic diseases affecting the epidermis. On the other hand, uncontrolled levels of 
apoptosis may have pathological consequences (Nicholson, 2000). In the skin, Stevens-
Johnson syndrome (SJS) is a specific subtype of erythema multiforme that is 
characterized by elevated levels of cell death (Inachi et al., 1997). This abnormal level of 
apoptosis often leads to separation of the epidermis from the dermis, causing severe 
blistering and shedding of the skin that closely resembles symptoms found in Kindler 
Syndrome patients (Abe et al., 2003) and in mice with ILK-deficient epidermis (Nakrieko 
et al., 2008). Consequently, patients suffering from this syndrome are left susceptible to 
infection due to the diminished protective capacity of the skin (Abe et al., 2003). Mice 
with epidermis-restricted inactivation of the Ilk gene exhibit a number of phenotypic 
defects, including reduced adhesion to the basement membrane and disrupted epidermal 
integrity (Nakrieko et al., 2008; Lorenz et al., 2007). As the external layer of protection, 
the skin is often exposed to external stressors such as UV radiation, a known generator of 
genomic instability and free radical species (Phillipson et al., 2001). Normally, 
keratinocytes are adequately self-protected against oxidative stress, through the 
production of endogenous antioxidants (Bito and Nishigori, 2012). However, if the 
epidermis becomes overloaded with UV-induced ROS, physiological antioxidant levels 
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are reduced and impair the cellular redox balance (Bito and Nishigori, 2012). 
Consequently, the cells undergo apoptosis. Thus, elucidating the involvement of ILK in 
suppressing intracellular ROS levels has important implications with respect to skin 
biology. In addition, UV irradiation is a common source of DNA damage, and based on 
my observations, ILK may be involved in regulating proper DNA repair. Additional 
experiments would need to be conducted to validate this hypothesis.  
 
4.3 Future Directions 
Recent work has shown a potential link between ILK and apoptosis; however, the 
definitive cause for how ILK-deficiency leads to increased levels of ROS and 
subsequently, apoptosis has yet to be determined. It would be worthwhile to investigate 
any alterations in the signalling pathways involved in regulating oxygen-derived radicals 
and to determine if they are directly downstream of ILK. For example, Rac1, a small 
GTPase, is regulated by ILK (Ho et al., 2012; Sayedyahossein et al., 2013). In addition to 
its role in controlling actin cytoskeletal reorganization (Filipenko et al., 2005), Rac1 has 
also been shown to mediate intracellular ROS production through its control over 
NADPH oxidase activation (Rygiel et al., 2008; Bokoch and Diebold, 2002). Specifically 
in cultured keratinocytes, we have demonstrated that Ilk gene inactivation leads to 
reduced activation of Rac1, resulting in impaired development of front-rear cell polarity 
(Ho et al., 2010; 2012). Thus, it would be interesting to investigate a possible correlation 
between levels of active Rac1 and NADPH oxidase activity. 
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I also showed that the increased levels of apoptosis in ILK-deficient keratinocytes may be 
caspase-mediated, based on the abnormal localization of Bax to the mitochondria and 
increased levels of cleaved caspase-3 and PARP in these cells. However, it has yet to be 
confirmed whether apoptosis can be prevented through the addition of a caspase 
inhibitor. Thus, Z-VAD-FMK, a cell-permeable, general caspase inhibitor, could be 
introduced to ILK-deficient cells in culture to determine if the cleaved caspase-3 levels 
could be reduced to those observed in control cells and apoptotic levels could be rescued. 
Also, as the majority of my experiments were focused on how apoptosis may be activated 
intracellularly, the study of the effect of Ilk inactivation on the extrinsic apoptotic 
pathway could help elucidate the mechanisms by which ILK-deficiency leads to 
increased apoptosis. The extrinsic apoptotic pathway involves the activation of 
transmembrane death receptors through the binding of apoptosis-inducing ligands 
(Ashkenazi, 2008). Cellular FLICE-inhibitory protein (c-FLIP) is a catalytically inactive 
homologue of caspase-8/10 that directly impedes with the formation of the Death 
Inducing Signalling Complex at the level of the death receptors (Peter, 2004). As both the 
intrinsic and extrinsic pathways activate executioner caspases, it would be interesting to 
see if cleaved caspase-3 and/or cleaved PARP levels can be diminished in ILK-deficient 
keratinocytes with the overexpression of c-FLIP (Kreuz et al., 2001).  
In addition to an increase in ROS levels, γH2A.X, an established marker of double-strand 
breaks, was also increased in ILK-deficient cells. However, despite using an indirect 
marker of DNA damage, the actually amount of damaged DNA was not quantitatively 
measured for comparison between the two cell types. I also demonstrated that under 
optimal culture conditions, the increase in γH2A.X levels correlates to elevated ROS in 
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ILK-deficient keratinocytes. However, elevated levels of γH2A.X could also be attributed 
to an impaired repair capacity of these cells. Repair of ROS-induced damage could be 
assessed through the measurement of anti-pyrimidine (6-4) pyrimidone photoproducts (6-
4PP) and cyclobutane pyrimidine dimers (CPD), two predominant forms of DNA 
damage. The quantification of 6-4PP and CPD products that remain in the genomic DNA 
of ILK-expressing and ILK-deficient epidermis can then provide an indication as to the 
extent of ROS-induced DNA damage that remains in each cell type over time (Biswas et 
al., 2014). Additionally, levels of proteins specifically involved in DNA single-strand or 
double-strand break repair, such as XRCC1 and Ku, respectively, could be quantified to 
assess any discrepancies in the repairing mechanisms of ILK-deficient keratinocytes.  
Finally, I demonstrated that ROS levels in ILK-deficient keratinocytes could be reduced 
with the addition of NAC. However, I did not measure and/or compare the scavenging 
capacity of cells lacking ILK to ILK-expressing cells. Thus, to determine if ILK-
deficiency is associated with an impaired capacity to quench oxidative radicals, the 
measurement of catalase activity would be informative. Similarly to peroxidases, catalase 
is the enzyme mainly responsible for the conversion of highly reactive H2O2 to water and 
oxygen (DeJong et al., 2007). The increase in ROS levels under optimal culture 
conditions in ILK-deficient keratinocytes may be attributed to a reduced detoxification of 
ROS by catalase. More experiments are necessary to confirm if catalase activity would be 
affected by ILK-deficiency.  
In summary, my studies demonstrate a novel role for ILK in maintaining keratinocyte 
viability. The epidermis serves to defend the body from harmful, external insults, 
including UV radiation and oxidative radicals. I have shown a newfound involvement of 
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ILK in modulating cellular ROS levels, as well as regulating stress-induced apoptosis, 
likely via the intrinsic, caspase cascade. Though the direct link between ILK and ROS 
has yet to be explored, I have delineated one of the possible mechanisms by which ILK 
modulates ROS-induced apoptosis in cultured keratinocytes. By achieving a better 
understanding of the function of ILK in promoting keratinocyte survival, we could 
identify the epidermal characteristics associated with the presence of ILK that are 
necessary to maintain normal development and sustainability of the skin. 
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